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PRODUCTION AND CHARACTERIZATION OF MONOCLONAL 
ANTIBODY AGAINST P60-KATANIN 
SUMMARY 
Since microtubules serve as structural components within cells and maintain cellular 
processes, they are needed to be organized actively. Microtubule severing is an 
important microtubule organization mechanism for cellular activities. In mitosis and 
meiosis, microtubule severing is thought to contribute to spindle reorganization. In 
neurons, all neuronal microtubules are suggested to be severed to relocate to populate 
in growing processes such as axons and dendrites. Katanin is the predominant, 
heterodimeric microtubule severing enzyme that disrupts contacts within the 
microtubule lattice using energy derived from ATP hydrolysis. Two katanin 
subunits, P60 and P80, have been identified. P60 subunit has the microtubule 
severing activity and P80 is thought to target katanin to the centrosome  and 
enhances the microtubule severing capacity of P60. 
Katanin is one of the key protein for organizing microtubular structure in variety of 
cell types. Studies suggest that katanin is responsible for changes in microtubule 
dynamics during mitosis/meiosis, concentrated at mitotic spindle poles, may severe 
microtubules from centrosome. Inhibition of katanin suppresses spindle-shortening 
processes was shown in fibroblast mitotic spindles and Caenorhabditis elegans 
meiotic spindles. In neurons, the level of P60-katanin was found to be very high in 
axons which actively grow towards their targets, at the tips of growing neuronal 
processes at certain developmental stages and in dendritogenesis.  When the axon 
reached its target and stopped growing, the level of P60-katanin was decreased. 
Blocking  function studies of P60-katanin indicate that katanin-mediated microtubule 
severing is responsible for the release of microtubules from the neuronal centrosome 
and decrease microtubule length throughout the neuronal cell body.  
Hybridoma technology has been developed by utilizing the immune system. The 
immune system is specifically responsible for targeting and removing the foreign 
macromolecules or antigens. In a humoral immune response, B lymphocytes are 
activated to secrete antibodies. Binding of an antibody inactivates viruses, microbial 
toxins and other foreign substances. Monoclonal antibodies are produced by 
hybridoma cell lines by tissue culturing. Each hybridoma is descended from a single 
B cell clone, hence the antibody it expresses is called monoclonal antibody. A 
monoclonal antibody belongs to one type of immunoglobulin class and has a single 
specificity so it recognizes only one epitope of the antigen and will rarely produce 
cross-reactions with others. This property brings the monoclonal antibodies the 
advantage as usage in larger areas than polyclonal antibodies. 
In this study, 1G6, the first monoclonal antibody against P60-katanin was produced. 
Firstly, RecP60 (Recombinat P60-katanin) protein which was produced from a 
specific part of rat P60-Katanin was expressed in Escherichia coli and used as the 
 xviii 
antigen. Monoclonal antibodies which were produced by hybridoma technology were 
screened with ELISA, examined in Western-blotting and immunocytochemistry. As 
a result of the study 1G6 was found to be the only antibody that recognized rat, 
mouse and human P60-katanin in Western-blotting and immunocytochemistry. 1G6 
is the first monoclonal antibody, showing the specific cellular localization of P60-
katanin of different species. Monoclonal antibodies are specific and produced 
permanently so they can be used in wide range of applications. Polyclonal antibodies 
have been used in studies with P60-katanin until now. Obtaining the hybridoma cell, 
the unlimited source, of the antibody against P60 results in a great advantage to 
investigate P60-katanin’s functions. 
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P60-KATANĐN’E KARŞI MONOKLONAL ANTĐKOR ÜRETĐLMESĐ VE 
KARAKTERĐZASYONU 
ÖZET 
Hücrelerin önemli yapısal bileşeni olan mikrotübüller hücresel süreçleri 
sürdürdükleri için aktif olarak organize edilmeleri gerekir. Mikrotübüllerin kesilmesi 
hücresel faaliyetler için önemli bir mikrotubul organizasyon mekanizmasıdır. Mitoz 
ve mayoz bölünmede iğ ipliklerinin reorganizasyonuna mikrotübüllerin kesilmesinin 
katkı sağladığı düşünülmektedir. Nöronlarda, mikrotübüllerin akson ve dentrit gibi 
gelişmiş hücre uzantılarına taşınması ve yerleşmesi için  kesilmesi gerektiği 
önerilmiştir. Katanin, başlıca mikrotübül ağını kesen heterodimerik bir proteindir ve 
bunun için gereken enerjiyi ATP hidroliziyle sağlar. Đki katanin altbirimi, P60 ve P80 
olarak tanımlanmıştır. P60 alt ünitesi mikrotübül kesme aktivitesine sahiptir, P80 alt 
ünitesi ise mikrotübül kesilme kapasitesini arttırmakta ve katanini sentrozoma 
yönlendirdiği düşünülmektedir. 
Katanin çeşitli hücre tiplerinde mikrotübül yapısını düzenleyen önemli proteinlerden 
biridir. Çalışmalar, kataninin mitoz/mayoz bölünme sırasında mikrotübül 
dinamiklerini değiştirmekten sorumlu olduğunu, mitotik iğ ipliği kutuplarında 
konsantre olması, mikrotübülü sentrozomdan kestiğini düşündürmektedir. Katanin 
inhibe edildiğinde, fibroblastta mitotik iğ ipliklerinin, Caenorhabditis elegans 
embriyosunda ise mayotik iğ ipliklerinin kısalma süreçlerinin de inhibe olduğu 
gözlenmiştir. Nöronlarda, hedefine doğru aktif olarak büyüyen aksonlarda, belirli 
gelişim evrelerinde büyüyen nöronal uzantıların uçlarında ve dendritogenezde P60-
katanin düzeyi çok yüksek bulunmuştur. Akson hedefine ulaştığında ve büyümeyi 
durdurduğunda ise katanin seviyesi düşmüştür. P60-kataninin işlevi bloklanarak 
yapılan çalışmalarda ise katanin aracılı mikrotubul kesilmesinin mikrotübülleri 
nöronal sentrozomdan serbestleştirmeden ve nöronal hücre gövdesinde mikrotubul 
boyunu kısaltmadan sorumlu olduğunu göstermiştir. 
Hibridoma teknolojisi bağışıklık sisteminden yararlanılarak geliştirilmiştir. 
Bağışıklık sistemi organizmaya yabancı olan makromoleküllerin veya antijenlerin 
spesifik olarak tanınması ve ortadan kaldırılmasından sorumludur. Antikor yanıtında, 
B lenfositler aktive olurlar ve antijene spesifik antikorları salgılarlar. Antikorun 
bağlanmasıyla virüs, mikrobiyal toksinler ve diğer yabancı maddeler inaktive edilir. 
Monoklonal antikorlar hibridoma hücre hatlarından doku kültürü yapılarak üretilirler. 
Her hibridoma tek bir B hücre klonu soyundan gelir, bu nedenle onun exprese ettiği  
antikor monoklonal antikor olarak adlandırılır. Monoklonal antikorlar bir 
immünglobulin sınıfına aittir ve tek tip spesifisite gösterirler. Bu yüzden antijenin tek 
bir epitopunu tanırlar ve nadiren diğer antijenlerle kross reaktivite verirler. Bu 
özelliğiyle polyklonal antikorlardan daha geniş alanlarda kullanım avantajına 
sahiptirler. 
Bu çalışmada, P60-katanin’e karşı ilk monoklonal antikor olan 1G6, üretildi. 
Öncelikle, sıçan P60-kataninin belirli bir bölgesinden üretilen RecP60 (Recombinat 
 xx 
P60-katanin) proteini, Escherichia coli de exprese edildi ve antijen olarak kullanıldı. 
Hibridoma teknolojisi ile elde edilen monoklonal antikorlar, ELISA ile tarandı, 
Western-blot ve immünsitokimya yöntemlerinde denendi. Çalışmanın sonucunda, 
1G6’nın Western-blot ve immunositokimya yöntemlerinde sıçan, fare ve insana ait 
P60-katanini tanıyan tek antikor olduğu belirlendi. 1G6, farklı türlere ait P60-
katanini spesifik hücresel lokalizasyonunda gösteren ilk monoklonal antikordur. 
Monoklonal antikorların spesifik oluşu ve üretiminin sürekliliği sayesinde geniş 
uygulama alanlarında kullanılabilirler. Şimdiye kadar P60-katanin ile yapılan 
çalışmalarda poliklonal antikorlar kullanılmaktaydı. P60’a karşı monoklonal 
antikorun, yani onu sınırsız üreten hibridoma hücre kaynağının elde elde edilmesi, 
P60-kataninin fonksiyonlarını araştırmak için büyük bir avantaj sağlayacaktır.  
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1.  INTRODUCTION 
1.1 Cytoskeleton  
Eukaryotic cells have protein fibers serving as structural components like a “skeletal 
system” in the cytoplasm which is called the “cytoskeleton”. For cells to function 
properly, they must rearrange their internal components as they grow, divide, and 
adapt to changing circumstances. They have to be correctly shaped, physically 
robust, and properly structured internally. Many have to change their shape and 
move from place to place. Eukaryotic cells have developed all these spatial and 
mechanical functions to a very high degree, and they depend on a remarkable system 
of the cytoskeletal filaments’ network.  
Below mentioned are the basic functions of the cytoskeleton: 
1) Pulls the chromosomes apart at mitosis and splits the dividing cell into two. 
2) Drives and guides the intracellular transport of organelles and vesicles from one 
part of the cell to another.  
3) Supports the fragile plasma membrane by providing the mechanical linkages that 
let the cells bear stresses.  
4) Enables several types of cell motility such as sperm to swim, fibroblasts and white 
blood cells to crawl across surfaces. 
5) Provides the machinery in the muscle cell to contract and in the nerve cell to 
extend an axon and dendrites. 
6) Guides the growth of the plant cell wall and controls the diversity of eukaryotic 
cell shapes. 
The  different functions of the cytoskeleton depend on the behavior of three protein 
families, assemble to form three main types of filaments: microtubules, 
microfilaments, and intermediate filaments which together form an elaborate 
interactive network. Each protein fibers of the cytoskeleton has distinct mechanical 
properties, dynamics, and biological roles, but all three cytoskeletal filament systems 
must normally function collectively (Alberts et al., 2008; Karp, 2010).
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Most eukaryotic cells contain all three types of cytoskeletal filaments, frequently 
concentrated in distinct locations. In the absorptive epithelial cells that line the lumen 
of the intestine, actin microfilaments are abundant in the apical region, where they 
are associated with cell-cell junctions and support a dense carpet of microvilli. 
Keratin intermediate filaments, forming a meshwork, connect microvilli and are 
tethered to junctions between cells. Lamin intermediate filaments support the inner 
nuclear membrane. Finally microtubules, aligned with the long axis of the cell, are in 
close proximity to major cell organelles (Figure 1.1) (Kreis and Vale, 1999). 
 
Figure 1.1 : Cytoskeletal filaments (Alberts et al., 2008). 
1.1.1 Microfilaments 
Microfilaments are also known as actin filaments are flexible tubes, 5-9 nm in 
diameter, composed of two-stranded helical polymers of the protein actin. Each 
filament is a twisted chain of identical globular actin molecules, all of which “point” 
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in the same direction along the axis of the chain. An actin filament possess a 
structural polarity, with a plus end and a minus end. Actin filaments able to grow by 
addition of actin monomers at either ends, but the rate of growth is faster at the plus 
end than at the minus end. Each free actin monomer carries a tightly bound ATP 
which is hydrolyzed to ADP soon after the incorporation of the actin monomer into 
the filament. Hydrolysis of bound ATP to ADP in an actin filament decreases the 
stability of the polymer, promoting depolymerization that helps the cell to 
disassemble filaments after they are formed. The function of actin filaments depends 
on a dynamic equilibrium between the actin filaments and the pool of actin 
monomers (Alberts et al., 2008). 
Actin filaments are dispersed throughout the cell and concentrated at the narrow 
layer of cytoplasm beneath the plasma membrane called the cortex. In this region, 
most actin filaments are arranged in a network that excludes most organelles from 
the cortical cytoplasm (Lodish et al., 2004). 
Actin filaments determine the shape of the cell surface and are necessary for whole-
cell locomotion, for cells to engulf a large particle by phagocytosis and to divide. 
The distinctive shape of a cell depends on the organization of actin filaments and 
membrane-microfilament binding proteins. By association with actin binding 
proteins, actin filaments can form stiff and relatively permanent structures, such as 
the microvilli on the brush-border cells lining the intestine or small contractile 
bundles that can contact and act like the “muscles” of the cell. They can also form 
temporary structures, such as the protrusions formed at the leading edge of a 
crawling fibroblast or a contractile ring that pinches the cytoplasm in two during cell 
division (Lodish et al., 2004; Garner et al., 2004). 
1.1.2  Intermediate filaments 
Intermediate filaments are ropelike fibers with many long strands twisted together to 
provide great tensile strength. The subunits of intermediate filaments are elongated 
fibrous proteins composed of an N-terminal globular head, a C-terminal globular tail, 
and a central elongated rod domain. The rod domain consists of an extended α-
helical region. Intermadiate filament proteins form stable dimer by wrapping around 
each other in a coiled-coil configuration. Two of the coiled-coil dimers associate by 
noncovalent bonding to form a tetramer and the tetramers bind to one another end-to-
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end and side-by-side by non-covalent bonding and generate the final intermediate 
filament (Helfand et al., 2003).  
Intermediate filaments’ main function is to provide cells mechanical strength and 
resistance to shear stress when cells are stretched. They are tough fibers assembled 
from a large diverse family of proteins. The components of the cytoskeleton are 
highly dynamic structures capable of rapid and dramatic reorganization. The most 
common intermediate filaments, found in the nucleus, are composed of lamins called 
nuclear lamina, underlie and strengthen the nuclear envelope in all eukaryotic cells. 
Other proteins that construct intermediate filaments are expressed preferentially in 
certain tissues: for example keratin-containing filaments in epithelial cells, desmin-
containing filaments in muscle cells, and vimentin-containing filaments in 
mesenchymal cells. (Lodish et al., 2004). 
Intermediate filaments are found in the cytoplasm of most animal cells. Typically 
crisscross the cytoplasm, forming an internal framework that surrounds the nuclear 
envelope and stretches to the plasma membrane. They are attached by adapter 
proteins to the plasma membrane at specialized cell-cell junctions called desmosomes 
and hemidesmosomes, which mediate cell-cell adhesion and cell-matrix adhesion, 
respectively, particularly in epithelial tissues (Helfand et al., 2003). 
1.1.3 Microtubules 
In all eukaryotic cells, microtubules bear important organizing roles. They are 
involved in many cellular processes. Cell division, cytokinesis, cell motility, 
outgrowth of processes, cellular trafficking and differentiation are included. They are 
in charge of attaching membrane-enclosed organelles and leading intracellular 
transport serving as system of tracks along which vesicles, organelles and other cell 
components carried with motor proteins.  
1.1.3.1 Microtubule structure 
Microtubules are rigid tubes composed of subunits of the protein tubulin, a 
heterodimer of α-tubulin and β-tubulin, bound tightly together by noncovalent 
bonding.  
Microtubules are arranged as a cylindrical tube, diameter of ~ 24 nm varying in 
length from hundred microns to a single micron in axons of nerve cells (Figure 1.2). 
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In a microtubule, lateral and longitudinal interactions between the tubulin subunits 
are in charge of maintaining the tubular form. Longitudinal interactions between 
heterodimers link the subunits head to tail at 8 nm intervals into a linear 
protofilament. Through lateral interactions, protofilaments associate side by side into 
a sheet and finally a cylinder to make microtubule. A single microtubule is 
comprised of 10–15 protofilaments, usually 13 in mammalian cells. The subunits in 
each protofilament in a microtubule all point in the same direction. Therefore, the 
microtubule itself has a distinct structural polarity, with α-tubulins exposed at one 
end called minus end and β-tubulins exposed at the other end, the plus end (Alberts 
et al., 2008; Lodish et al., 2004; Conde and Cáceres, 2009). The dynamic properties 
of the two ends of a microtubule are different. In vitro, in a concentrated solution of 
pure tubulin, tubulin dimers will add to either end of a growing microtubule, 
although they add more rapidly to the plus end than the minus end (Wittmann et al., 
2001). 
 
Figure 1.2 : Microtubule structure (Lodish et al., 2004). 
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α- and β- tubulin monomers are proteins of about 450 amino acids each and are about 
50 % identical at the amino acid level. Each monomer has a molecular mass of about 
50,000 Da. On each α or β monomer GTP binding sites are existed. Those sites are: 
• Non-hydrolyzable site when binding GTP to α-tubulin is irreversible and the 
hydrolization incident of GTP does not occur.  
• Exchangeable site on β-tubulin binds GTP reversibly and hydrolyzes it to 
GDP.  
In the atomic structure of the tubulin subunit, the GTP bound to α-tubulin is trapped 
at the interface between the monomers and is thus nonexchangeable and never 
hydrolized. The GTP which lies at the surface of the β-tubulin monomer is freely 
exchangeable with GDP. The guanine bound to β-tubulin modulates the addition of 
tubulin subunits at the ends of a microtubule (Lodish et al., 2004). 
1.1.3.2 Microtubule dynamics and organization 
Like microfilaments and intermediate filaments, microtubules are not randomly 
distributed in cells. In animal cells microtubules radiate from the centrosome and this 
structure is called the primary microtubule-organizing center (MTOC). Microtubules 
are formed by outgrowth from MTOCs, which control the number of microtubules 
formed, their location, and their orientation in the cytoplasm. MTOC is a collection 
of microtubule-associated proteins that sometimes but not always contains a pair of 
centrioles. Because microtubules assemble from the MTOC, microtubule polarity 
becomes fixed in a characteristic orientation. In many nondividing animal cells, the 
MTOC is located at the center of the cell near the nucleus, and the radiating 
microtubules are all oriented with their (+) ends directed toward the cell periphery. In 
most interphase animal cells, the (-) ends of microtubules are proximal to the MTOC. 
In the nerve cells, all microtubules in the axon point their plus ends toward the axon 
terminal (Lodish et al., 2004).  
The MTOC organizes cytosolic microtubules by nucleating the microtubule 
assembly and then anchoring and releasing microtubules. γ- Tubulin is the third 
member of the tubulin superfamily, is not a part of the tubulin subunit, but it is one of 
the protein that MTOC contains, for the first assembling a ring of αβ-tubulin dimers, 
than to add such dimers to a preexisting microtubule structure. γ- tubulin is also 
found as a part of a γ-tubulin ring complex (γ-TuRC). γ-TuRC can directly nucleate 
microtubule assembly at subcritical tubulin concentrations that is, at concentrations 
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below which polymerization would not take place in the absence of the γ-TuRC. By 
providing organizing centers containing nucleation sites, and keeping the 
concentration of free αβ-tubulin dimers low, cells can thus control where 
microtubules form (Lodish et al., 2004).  
During the cellular processes, microtubules undergo dramatic alterations. One is 
called “dynamic instability” where microtubules’ length oscillate between growth 
and shortening phases by reconfiguration through assembly and disassembly  (Figure 
1.3) (Kosik and Baas, 1999; Lodish et al., 2004). This ossilation stems from the 
intrinsic capacity of tubulin molecules to hydrolyse GTP. Each free tubulin dimer 
contains one tightly bound GTP molecule on β-tubulin site. The GTP is hydrolyzed 
to GDP, shortly after the subunit is added to a growing microtubule. Thus, this leads 
to its elongation and formation of the protofilament (Singh et al., 2008). 
The GTP-associated tubulin molecules are packed efficiently together in the wall of 
the microtubule, but tubulin molecules carrying GDP have a different conformation 
and bind less strongly to each other. The majority of β-tubulin in the microtubule 
fiber is in the GDP-bound form but ‘‘capped” with GTP-bound tubulin dimers at the 
plus end. When polymerization is proceeding rapidly, tubulin molecules add to the 
end of the microtubule faster than the GTP hydrolysis on the microtubule structure 
forming the GTP cap. When tubulin at the free end of the microtubule hydrolyzes its 
GTP before the next tubulin has been added, conformational change results and rapid 
depolymerization of the microtubule starts. 
 
Figure 1.3 :  Dynamic instability (Alberts et al., 2008). 
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Cells are able to modify the dynamic instability of their microtubules. As cells enter 
mitosis, switching between growing and shrinking much more frequently than 
interphase cytoplasmic microtubules.When a cell has differentiated into a specialized 
cell type and taken on a definite fixed structure, the dynamic instability of 
microtubules is often suppressed by proteins that bind to the ends of microtubules.  
Most differentiated animal cells are polarized. The cells polarity is a reflection of the 
polarized systems of microtubules, which help to position organelles in their required 
location and to guide the streams of traffic moving between one part of the cell and 
another. Transport occurs along microtubules when the appropriate motor binds to a 
cargo and simultaneously binds to the rail. The motor then moves along the rail in 
such a “walking” manner powered by energy derived from hydrolysis of ATP 
(Mallik and Gross, 2004). Impaired axonal transport of molecules by motor proteins 
is linked to the pathogenesis of Alzheimer’s disease (Stokin and Goldstein, 2006) 
1.1.3.3 Microtubules’ regulation and severing 
Microtubule assembly and stability and their association with other cell structures are 
regulated by a large variety of accessory proteins called microtubule associated 
proteins (MAPs) (Table 1.1). MAPs are classified into two groups. One group 
stabilizes microtubules: MAP1A and MAP1B are found in neurons as well as in 
nonneuronal cells. MAP4, is found in most of the cells. In mitosis, MAP4 regulates 
microtubule stability, and CLIP170 cross-links microtubules to chromosomes. MAP2 
and Tau is found only in neurons (Lodish et al., 2004).  
Table 1.1: Properties of MAPs (Lodish et al., 2004). 
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The second group of MAPs destabilizes microtubules: Katanin, severs intact 
cytosolic microtubules. Op18 (stathmin) increases the frequency of rapid 
disassembly of microtubules in the mitotic spindle (Lodish et al., 2004). 
Binding to the tubulin subunits, MAPs can act on a microtubule directly, or they can 
restrict access to the microtubules to other MAPs or motor proteins by binding to 
microtubule (Baas and Qiang, 2005). A broad range of MAPs functions suggest that  
coordinated action of MAPs leads to the proper microtubule functioning (Maiato et 
al., 2004). Modulating the binding of MAPs is accomplished by the reversible 
phosphorylation of the MAP. Phosphorylated MAPs are unable to bind to 
microtubules; thus, they can control the length of microtubules, promoting 
microtubule disassembly. MAP kinase, a key enzyme for phosphorylating MAPs, is 
a participant in many signal-transduction pathways, indicating that MAPs are targets 
of many extracellular signals. MAPs, especially MAP4, are also phosphorylated by a 
cyclin-dependent kinase (CDK) that plays a major role in controlling the activities of 
various proteins in the course of the cell cycle (Lodish et al., 2004). 
Microtubules must be actively organized and transported in the cell to serve as 
structural components and maintain cellular processes. Dynamic instability is not 
sufficient to explain the entirety of microtubule behaviors for these cellular activities. 
Microtubules can be severed along their length, and this affects microtubule 
dynamics (Baas et al., 2005; Quarmby, 2000). Microtubule severing activity is first 
identified and studied in mitotic extracts of Xenopus laevis eggs (Vale, 1991; 
McNally and Vale, 1993).  
In mitosis and meiosis, microtubule severing on the spindles is thought to contribute 
to spindle reorganization (Ahmad and Baas, 1995). Severing near the centrosome 
could provide the opportunity for minus-end-directed flux of the mitotic spindle 
microtubules during metaphase (Mitchinison, 1989). Microtubule is released from 
minus end or severed by a severing enzyme and transport of these non-centrosomal 
microtubules are conveyed by motor proteins (Keating et al., 1997). 
In neurons, microtubules were observed to extend from the cell body into the growth 
cone within the axon and dendrites. Important events for axonal differentiation such 
as elongation, branching, navigation, retraction, are achieved by changes in the 
configuration and behavior of microtubules (Baas and Buster, 2004). Suggesting that 
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all neuronal microtubules are nucleated at the centrosome, the tubulin proteins or 
microtubule arrays must be actively transported from the cell body into periphery, 
and then relocated to populate in axons and dendtires in order to maintain elongation 
and branching. Variety of cell types transform their microtubule array from one type 
of organization to another is explained by a model called “cut and run” (Baas et al., 
2005). According to this model long immobile microtubules are severed into short 
pieces and rapidly transported into a new configuration, before the short pieces again 
elongate and lose their motility (Figure 1.4). Motor proteins and treadmilling have 
the main roles in transporting microtubules by carrying them and maintaining their 
dynamicity, recpectively. Due to the fact that long microtubules are stabilized by 
crosslinking with other components of the cytoplasm, longer microtubules can not be 
carried by motor proteins and tubulin subunits can not dissociate and then associate 
to longer microtubules by treadmilling mechanism. Consequently, the key step of the 
microtubule transport is the severing of long microtubules to be short enough. (Baas 
et al., 2005, 2006). 
 
Figure 1.4 : The ‘cut’ and ‘run’ model (Baas et al., 2006). 
 
Microtubule severing might be regulated by the stabilizing-MAP protection. It was 
observed that katanin-induced microtubule severing is much more active in 
interphase when frog homolog of MAP4 is depleted (McNally et al., 2002) and 
severing is more active in mitotic extracts based on phosphorylation of proteins, 
except katanin. Phosphorylated MAP4 lose its association with the microtubules. In 
Microtubule transport and axonal branch formation regulation by microtubule-
severing proteins.  
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the model, fibrous MAPs protect the lattice of the microtubule from being accessed 
by katanin (Baas et al., 2005). Phosphorylation of the MAPs results in their 
detachment from the microtubule, thus enabling katanin to gain access. Signaling 
cascades can regulate microtubule severing by causing MAPs to dissociate from the 
microtubules at the site where an axonal branch is starting to form, thereby 
permitting katanin to break the microtubules into shorter mobile pieces where needed 
(Baas et al., 2006). Tau has been shown to be important for strong protection against 
severing by either katanin or spastin which is another microtubule severing protein. 
Hyperphosphorylation of tau causes it to dissociate from microtubules so 
microtubules become more accessible to katanin and this process is also observed in 
Alzheimer’s disease pathology (Baas and Qiang, 2005). Tau that shields 
microtubules from severing has been found to have greater protection in the case of 
katanin (P60 subunit) than spastin (Yu et al., 2008). 
1.2 Microtubule Severing Protein, Katanin 
Katanin is the predominant, heterodimeric microtubule severing protein and has the 
ATPase activity which disrupts contacts within the microtubule lattice using energy 
derived from ATP hydrolysis. Katanin is characterized by purification from sea 
urchin eggs and its name is originated from the Japanese word for samurai sword 
“katana” (McNally and Vale, 1993). Two katanin subunits, P60 and P80, have been 
identified. P60 subunit has the microtubule severing activity and P80 is thought to 
target katanin to the centrosome and enhances the microtubule severing capacity of 
P60 (Hartman et al., 1998). 
Katanin is responsible for changes in microtubule dynamics during mitosis. Katanin 
is concentrated at a microtubule-dependent structure at mitotic spindle poles, 
suggesting katanin may sever microtubules from their centrosomal attachments 
(McNally and Thomas, 1998) and mediates the disassembly of microtubule minus 
end during poleward flux (McNally et al., 1996; Quarmby 2000; Buster et al., 2002). 
In addition, Drosophila melanogaster katanin orthologues appear to function 
primarily on anaphase chromosomes, where it stimulates microtubule plus-end 
depolymerization and Pacman-based chromatid motility (Zhang et al., 2007). 
Inhibition of katanin inhibits spindle-shortening processes in fibroblast mitotic 
spindles and Caenorhabditis elegans meiotic spindles (McNally et. al., 2006).  
 12 
Katanin may have other functions distinct from its role in cell division. In neurons, it 
was shown that katanin is present at the centrosome and widely distributed within the 
axon and all neuronal compartments (Baas et al., 2006). The level of P60-katanin 
was found very high in axons actively growing towards their targets, but then it 
decreased when the axon reached its target and stopped growing (Yu et al., 2005). 
High P60-katanin levels were also found at the tips of growing neuronal processes at 
certain developmental stages and in dendritogenesis. Blocking the function of P60-
katanin prevents microtubule release from the centrosome and profoundly increases 
microtubule length throughout the neuronal cell body indicating that katanin-
mediated microtubule severing is in charge of releasing microtubules from the 
neuronal centrosome (Ahmad et al., 1999; Karabay et al., 2004). Microtubule 
severing by katanin is also essential for regulating the length of the microtubules 
after their release (Ahmad et al., 1999). Katanin is likely to be the principal means 
for generating the short microtubules observed in axonal growth cones and interstitial 
branch points (Dent et al., 1999). Relatively short microtubules are mobile. In ‘cut 
and run’ model, katanin break the lattice of the microtubule polymer in order to 
generate mobilizable short microtubules which are transported to newly growing 
neuronal processes of neurons (Baas et al., 2005).  
1.2.1 AAA superfamily  and structure of Katanin 
Katanin is a member of AAA (ATPases Associated with various cellular Activities) 
superfamily of ATPases (Confalonieri and Duguet, 1995). All members of the AAA 
family are Mg2+dependent ATPases. The AAA motif is defined by a conserved ATP-
ase domain of 230 to 250 amino acids that includes the Walker signature sequences 
of P-loop ATPases and other regions of similarity unique to AAA proteins. The 
classical AAA proteins are easily recognized by their strong sequence conservation 
of 30% identity in this domain (Patel and Latterich, 1998; Vale, 2000).  
Although AAA proteins are monomers, they function as an oligomeric ring complex 
(Hartman et al., 1998, Patel and Latterich, 1998). Katanin is present in equilibrium 
between monomers and oligomers. In this case of the katanin, the oligometric state 
has been shown to be hexameric ring where ATP binding induces structural 
reorganizations at the interface region which increases interactions between adjacent 
AAA domains as well as between the AAA protein and its target. (Hartman and 
Vale, 1999). This creates a tense state of the AAA-target protein complex. The 
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tighter subunit-subunit interactions in turn accelerate ATPase reaction. Once the 
AAA modules are in ADP state, the complex reverts to a relaxed configuration in 
which interactions between AAA domains and the target protein weaken. Rings also 
provide a framework for binding target protein at multiple sites. If the ring-binding 
sites change their positions during the ATPase cycle, then tension could be applied to 
a bound protein (Vale, 2000). 
P60, the 60 kDa subunit is 491 amino acid long polypeptide (Karabay et al., 2004) 
and composed of an N-terminal domain that binds microtubules (Hartman and Vale, 
1999) and a conserved C-terminal domain sharing homology with a large family of 
ATPases. BLAST search revealed that ortholog of P60 exists in C. elegans, in 
Arabidopsis thaliana and there are vertebrate homologs of P60 (Hartman et al., 1998; 
Stoppin-Mellet et al., 2003; Bouquin et al., 2003; Yang et al., 2003). P60 alone 
displays a microtubule-stimulated ATPase activity. Although, when comparing the 
rates of microtubule disassembly, P60 is half as active as P60/P80 (Hartman et al., 
1998). P80, the 80 kDa subunit is 658 amino acid long (Karabay et al., 2004) and 
composed of an N-terminal WD40 repeat domain, a central proline-rich domain and 
a C-terminal domain required for dimerization with the catalytic P60 subunit 
(Hartman et al., 1998). 
It has been found that katanin’s P60 subunit exhibits both microtubule-stimulated 
ATPase activity and microtubule- severing activity in the absence of the P80 subunit. 
P80 can enhance P60 mediated microtubule severing by increasing affinity of P60 to 
microtubules (McNally et al., 2000). P60/P80 was found to have a two-fold higher 
microtubule severing activity compared to P60  alone. The WD40 repeat domain of a 
human P80 homolog was shown to be sufficient to target the P80 homolog to 
interphase centrosomes (Hartman et al., 1998).  WD40 domain and con80 domain of 
P80 katanin can enhance P60 mediated microtubule severing by increasing affinity of 
P60 to microtubules. (McNally et al., 2000). On the other hand, it was also found that 
WD40 domain of P80 acts as a negative regulator of microtubule severing by P60. 
(McNally and Thomas, 1998; Hartman et al., 1998; McNally et al., 2000).  
In neurons, the levels of P60-katanin fluctuate at the developmental stage. In 
addition, katanin is typically viewed as a heterodimer, but it has been recently shown 
that the two subunits are not present within cells at equimolar levels. In fact, the ratio 
of the two subunits varies in different tissues and at different stages of development, 
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suggesting that the activity of the P60 subunit might be influenced by the levels of 
the P80 (Yu et al., 2005). In addition, a recent research also reported that the C 
terminal domain of a candidate tumor suppressor LAPSER1/LZTS2 (LAPSER1) 
inhibits katanin-mediated microtubule severing in vitro by binding to P80 katanin 
(Sudo and Maru, 2008). 
1.2.2 Microtubule severing mechanism and regulation of Katanin 
Katanin breaks microtubules along the length, removing the tubulin dimers from the 
wall of the microtubule. Released tubulin dimers are able to repolymerize again, so 
they are not phosphorylated, proteolyzed or otherwise changed. Katanin can 
disassemble microtubules under conditions that favor spontaneous assembly of 
tubulin into microtubules. This means that either katanin inhibits polymerization of 
tubulin dimers or dissociates tubulin dimers from microtubules faster than they re-
associate (McNally and Vale, 1993). 
Tubulin subunits dissociate very slowly from the microtubule wall. Severing of a 
microtubule at a specific spot requires the subunits to be dissociated from tightly 
bound neighbours above, below and on two sides. However, in the presence of ATP, 
katanin disrupts these tubulin–tubulin contacts and can sever and dismantle a taxol-
stabilized microtubule within a couple of minutes (Vale, 2000). Microtubules act as a 
scaffold for katanin to oligomerize into a ring structure after it has exchanged its 
ADP for ATP. As a consequence of ATP hydrolysis and subsequent phosphate 
release, the katanin undergoes a conformational change leading to mechanical strain 
that destabilizes tubulin-tubulin contacts. The ADP-bound katanin dissolutes from 
the complex (Hartman and Vale 1999; Quarmby, 2000; McNally et al., 2000). This 
model suggests several possible points of regulation: a nucleotide-exchange factor 
could regulate loading of P60 with ATP; accessibility to microtubules could be 
regulated by removal of protective MAPs; oligomerization sites on P60 could be 
reversibly masked by regulatory factors; and other factors could stimulate or inhibit 
ATP hydrolysis and severing (Quarmby, 2000).  
Although may katanin rich and is widely distributed in neurons, it should not sever 
microtubules everywhere. There should be a control mechanism which allows 
katanin to be locally activated/deactivated or being transferred to sites where 
microtubules need to be severed (Karabay et al., 2004). Activity of katanin might be 
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regulated by its synthesis and degradation levels. Tight regulation of the levels of 
katanin was observed in the neuron during axonal development (McNally et al., 
2002), where katanin levels are high during their most active phases of growth but 
drop once axons have contacted their targets (Karabay et al., 2004). There were some 
factors (like cyclinB/cdc2, cyclinB/cdc1) discovered that changed microtubule-
severing activity in M-phase Xenopus egg extract. However, experiments with 
isolated katanin showed that it is not directly activated or phosphorylated (McNally 
and Thomas, 1998;  McNally et al. 2002). Activity of katanin might be also regulated 
indirectly by other MAP’s which would restrict accession of katanin to microtubules 
(Baas and Qiang, 2005) as mentioned in detailed in the section 1.1.3.3. 
1.3 The Immune System 
Immunity is a defense mechanism against foreign substances. Microbes, 
macromolecules such as proteins and polysaccharides are included. The network of 
cells and molecules responsible for defending the body constitude the immune 
system. When an organism is threatened by microorganisms, viruses, the immune 
response acts to provide protection (Abbas and Lichtman, 2003). The first issue of 
the immune system is keeping out the foreign substances. If the system fails to keep 
them away, the foreigner will be seeked out and destroyed in the body. The key to a 
healthy immune system is its remarkable ability to distinguish the structure between 
the body’s own and foreign molecules (Janeway et al., 2005). 
The cells in the immune system specifically responsible for targeting and removing 
the foreign macromolecules or antigens are lymphocytes. They circulate in blood and 
lymph and populate areas of the body known as lymphoid tissues such as the spleen, 
lymph nodes, thymus, tonsils, adenoids, and Peyer's patches (Miller, 1996). There 
are two broad immune response classes that has specificity and memory: Antibody 
responses and cell-mediated immune responses.  
The components of cell mediated immune responses are lymphocytes (T cells and B 
cells), plasma B cells, antigen-presenting cells (macrophages, dendritic cells) and 
memory B and T cells (Stites and Terr, 1991; Ruebush, 2007). In Antibody 
responses, B cells are activated to secrete antibodies, which circulate in the 
bloodstream and permeate the other body fluids. Binding of an antibody inactivates 
viruses, microbial toxins and other foreign substances (Brum et al., 1994). 
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Antibodies and T lymphocytes eliminate extracellular and intracellular microbes, 
respectively. These functions often require the participation of the nonlymphoid 
effector cells and other defense mechanism (Abbas and Lichtman, 2003). Activated 
T cells react directly against the antigen that is presented on the surface of a host cell, 
for example, a virus-infected host cell that has viral antigens on its surface is 
eliminated by T cell. In other cases, the T cell produces signal molecules that activate 
macrophages to destroy the microbes by phagocytosis (Cummings, 1996).  
Immunological memory causes to “remember” each pathogen by a signature antigen. 
The specific immune response requires the recognition of antigens during “antigen 
presentation” process. Antigen specificity allows for the generation of responses that 
are fit to specific pathogens or pathogen-infected cells. The ability to mount these 
responses is maintained in the body by “memory cells” (Pancer and Cooper, 2006; 
Janeway et al., 2005). After the subsequent exposure to antigen the immune 
response’ lag period is shorter and the response is greater than the primary response 
even the antigen is represented again after some weeks, months or even years 
(Alberts et al., 2002). 
The specific immune response may be divided into five phases. The first phase starts 
by the specific recognition of antigens. This recognition guides to the activation of 
the lymphocytes that recognize the antigen and concludes in the development of 
effector mechanisms that mediate the physiologic function of the response which is 
called the elimination of the antigen. After the antigen is eradicated, the immune 
response subsides (returns to its basal resting state by apoptosis of antigen-stimulated 
lymphocytes) and homeostasis is restored (Abbas and Litchman, 2003). 
According to “clonal selection hypothesis”, antigen-specific clones of lymphocytes 
develop independently before exposuring to antigen. Cells of each clone arising from 
a single precursor are capable of recognizing and responding to a distinct antigenic 
determinant by their different antigen receptors exposed on their surface. The 
activation of lymphocytes requires firstly the antigen and secondly the microbial 
products or the non-specific immune components to microbes (Abbas and Litchman, 
2003).   
Activated lymphocytes synthesize and secrete cytokines which stimulate the growth 
and differentiation of the lymphocytes, cytokine receptors to make lymphocytes 
more responsive, many other proteins for gene transcription and cell division. In 
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response to these mechanisms, the antigen specific lymphocytes proliferate which is 
named clonal expansion. Some of the cells differentiate into effector cells, including 
helper T cells, Cytolytic T lymphocytes and antibody secreting B cells. Some of 
these B cells are identifiable as plasma cells. Plasma cells develop in lymphoid 
organs and at sites of immune responses and often migrate to bone marrow where 
some of them may survive even after the antigen is eliminated. These kind of plasma 
cells are the result of differentiation into memory cells. The same differentiation also 
accomplished for antigen-stimulated T cells. Memory B and T cells may survive in a 
functionally dormant or slowly cycling state for many years after the antigen is 
eliminated. Thus, the cells ensures rapid and enhanced responses to subsequent 
exposures to antigens (Abbas and Litchman, 2003). 
1.4 Properties and Interactions of Antibodies and Antigens 
Antibodies are serum immunoglobulins that specifically bind antigens in both the 
recognition phase of the antigen and the effector phase of the specific immune 
response. The first antibodies are produced in a membrane bound form by newly 
formed B lymphocytes, and these membrane molecules function as B cell receptors 
for recognition of the antigen. The interaction of antigen with membrane antibodies 
of immature B cells initiates B cell responses with the aid of a helper T cell and it 
differentiates into an antibody-secreting effector cell. These cells express and secrete 
large amounts of soluble antibody, which has the identical antigen binding site as its 
antigen receptor exposed earlier on the surface. All secreted antibody molecules from 
one B cell clone have the same specificity for their antigen binding site (Cummings 
1996). 
An antigen is any substance that may be specifically bound by an antibody molecule 
or T cell receptor. Any substance that activates immune response is called 
immunogen. All immunogens are antigens which react with the products of immune 
system, but all antigens are not immunogens. The immunogen antigens are in the 
structure of proteins, carbohydrates and phospholipids. The antigens that are not 
immunogens are smaller molecules may bind to antibodies, but can not activate B 
cells so they do not trigger immune response on their own. This kind of antigen is 
called hapten. Low molecular weight (1000 to 10000 Da) compounds including 
many drugs and antibiotics are haptens, hence they are conjugated to carrier proteins 
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in order to make them immunogen that cause to generate specific antibodies. 
Macromolecules are usually much bigger than the antigen-binding region of an 
antibody molecule. Antigens bind to antibodies with their small portions called 
antigenic determinants or epitopes. Antigens, typically contain multiple 
determinants, some of which may be repeated, and each of which, can be recognized 
by an antibody or receptors that belong to cells responsible for immunity (Stites and 
Terr 1991; Abbas and Litchman 2003; Ruebush 2007). 
The two hallmarks of immunoglobulins are the diversity which meets the different 
antigenic structures and the specifity of each to select the one of the suited antigen in 
the environment.  
The structure of immunoglobulins are glycoproteins composed of 82-96 % 
polypeptide and 4-18 % carbonhydrate (Stites and Terr, 1991). The simplest 
antibodies are Y-shaped tetrameric molecules consisting of two identical light (L) 
chains (about 220 amino acids/chain) and two identical heavy (H) chains (about 440 
amino acids/chain). The four chains interact with each other by noncovalent and 
covalent (disulfide) bonds (Lewin, 2004; Alberts et al., 2002; Janeway et al., 2005). 
Light chains and heavy chains share the same organization consisting of two 
principal regions: the N-terminal variable region (V region); and the C- terminal 
constant region (C-region). The light chain has one variable (VL) and one constant 
(CL) domain, while the heavy chain has one variable (VH) and three or four constant 
(CH) domains (Figure 1.5). 
The antibody has two identical antigen-binding sites in the variable domains. The 
variable domain (V) is generated by the interaction of V regions of light chain and 
heavy chain. Hundreds of V domains in different amino acid combinations create 
various antibodies to recognize diverse antigens. There are also three small 
hypervariable regions in the V domains of both chains. These regions are called 
complementarity determining regions (CDRs: CDR1, CDR2, CDR3) which protrude 
as loops at the end of V domain to form the three dimensional antigen-binding 
surface that is complementary to the antigen epitop (Figure 1.5 A-B). The 
effectiveness of antigen binding of the antibody molecule is increased by the hinge 
region, which allows flexibility to accomplish the required distance between the two 
antigen-binding sites to interact properly with the antigen (Abbas and Lichtman, 
2003). 
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Figure 1.5 : Structure of a typical immunoglobulin (antibody) protein.  
 
 
The protective properties of antibodies are due to their tails, the portion of heavy 
chain constant regions, which is called Fc region. This region acquire the antibody 
different effector functions, such as activating the complement system, attaching to 
phagocytic cells, transversing the placenta from mother to fetus. Antibody molecules 
can be divided into distinct classes and subclasses on the basis of differences in the 
amino acid sequence of their heavy constant regions including the Fc portions. In 
mammals, they are arranged as five classes, IgA, IgD, IgE, IgG, and IgM, which are 
named by the Greek letters- α, δ, ε, γ, and µ, respectively (Abbas and Lichtman, 
2003; Alberts et al., 2008).  
The isotype of IgG has four subclasses (IgG1, IgG2, IgG3 and IgG4), having γ1, γ2, γ3, 
γ4 heavy chains. IgG constitutes approximately 75 % of the total serum 
immunoglobulins, hence it is the dominant class in serum during a secondary 
immune response. IgG is the only isotype that crosses the placenta by its Fc region 
(passive immunity) (Minn and Quintans, 1999). IgA is the predominant 
immunoglobulin class in the mucosal immune system and appears to be an efficient 
antiviral antibody and also found in milk. IgA exists in two forms, IgA1 (90 %) and 
Hypervariable regions (CDR) of variable domains (A) determine the antigen 
specificity by the interaction of the antigen-epitope with CDRs (B) (Adapted 
from Burmester and Pezzutto 2003).  
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IgA2 (10 %) that have α1 and α2 chains, respectively. IgM is a pentameric isotype 
which is synthesised in early immune responses. IgM has µ heavy chains and it 
constitutes 8-10% of the total serum immunoglobulins and it is also expressed on the 
surface of naive B cells. IgD has δ heavy chains and it is the predominant 
immunoglobulin which is localized on the surface of naive B lymphocytes, as IgM. 
IgE is responsible for many common allergies and may protect against parasitic 
infections. It binds to Fc receptors on mast cells and eosinophils and triggers mast 
cell degranulation and cell-mediated cytotoxicity involving eosinophils. (Abbas and 
Lichtman, 2003; Janeway, 2005). 
1.5 Hybridoma Technology and Monoclonal Antibodies 
Monoclonal antibodies are produced by hybridoma cell lines which can be produced 
in tissue culturing. In hybridoma technology, hybridomas are hybrid cells which are 
produced from the fusion of B cells and the myeloma cell line. In this technique, the 
idea is combining of two valuable cells together. B cells are derived from the 
lymphatic tissues of immunized animals and the myeloma cell line brings 
immortality to B cells when they are fused together (Figure 1.6).  
Each hybridoma is descended from a single B cell clone, so the antibody it expresses 
is called monoclonal antibody. Monoclonal antibody has a single specificity and is in 
one type of immunoglobulin classes. Each monoclonal antibody is monospecific 
hence it recognizes only one epitope of the antigen (Burns, 2002). 
In 1976, Georges Kohler and Cesar Milstein published the method for the production 
of monoclonal antibodies by hybridomas that come from mouse splenocytes and 
their myeloma fusion partner. Kohler’s and Milstein’s contribution, for which they 
were awarded together with Niels K. Jerne the 1984 Nobel Prize in Physiology 
(Mechetner, 2007). As described above, their technique was to immunize mice with a 
pathogen and then fuse their B-lymphocytes taken from the spleen with mutant non-
secreted myeloma cells of mice. After limited dilution cloning and selection, 
hybridomas represent a pure and unlimited source of monoclonal antibodies with the 
desired antigen specificity (Chiarella and Fazio, 2008). 
The steps of hybridoma technology are summarized as follows: Mice are immunized 
with desired antigen, in order to produce antibody against this antigen. Then, the 
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most actively immunized mouse is selected by Enzyme Linked Immunosorbent 
Assay (ELISA) which is an immunologic assay. The most actively immunized 
mouse’s lymphoid organs are taken to isolate antibody producing B lymphocyte and 
myeloma cells are detached from their cultured flasks. Polyethyleneglycol (PEG) is 
used to fuse the two types of cells. Cells that are subjected to fusion will be cultured 
in Hypoxanthine Aminopterin Thymidine (HAT) selective medium. B lymphocytes 
can have a limited life time up to 4-5 days in cell culturing. Myeloma cells are the 
immortal cells that lose their reproduction control mechanism but sensitive to HAT. 
Therefore, the two types of unfused cells die and remained hybridomas continue to 
divide in culture plates. Hybridoma colonies that produced antibodies against desired 
antigen are detected by ELISA. 
In the selected well which has antibody response, there can be more than one 
hybridoma colony which can result in polyclonal response. By “limited dilution” 
method, the cells in antibody responding wells are dispersed to new culture plates in 
order to get hybrid colony produced from single cell. Besides, hybridoma colonies 
that synthesize specific monoclonal antibody for desired antigen are selected by 
cross-reactivity ELISA method.After limited dilution and selection hybridomas are 
cultured in large scale and monoclonal antibodies are purified from their collected 
growth media. 
HAT medium which is the most common selection medium, is used for the selection 
of hybridomas. Aminopterin inhibits de novo pathway which synthesize nucleotides 
from small-molecule precursors (Figure 1.7). Normal animal cells can also 
synthesize nucleotides from the partial breakdown products of nucleic acids such as 
hypoxanthine and thymidine (salvage pathway). The salvage pathway relies on the 
presence of the enzyme hypoxanthine guanine phosphoribosyl transferase (HGPRT). 
The mouse myeloma cell line is an HGPRT deficient (HGPRT−) mutant strain 
(Chung et al., 2000). Therefore, unfused myeloma cells die in HAT medium and 
unfused B cells die as they have a short life span in cell culture. In this way, only the 
B-cell-myeloma hybrids survive in the HAT medium culturing. 
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Figure 1.6 : General steps of hybridoma technology (Goldsby et al., 2003). 
 
 
Figure 1.7 : Pathways for nucleotide synthesis (Adapted from Lodish et al., 2004). 
1.6 Aim of the Study 
Microtubules are structural cytoskeletal components maintaining cellular processes, 
must be actively organized in the cell. Microtubule severing is an important 
mechanism for microtubule dynamics for cellular activities. In mitosis and meiosis, 
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microtubule severing on the spindles is thought to contribute to spindle 
reorganization (Ahmad  and Baas, 1995). In neurons, microtubules are suggested to 
be severed to generate mobilizable microtubules to be transported in growing 
processes such as axons and dendrites (Baas et al., 2005). Katanin is an important 
heterodimeric protein that severs microtubule network to regulate cellular functions 
using energy derived from ATP hydrolysis (McNally and Vale, 1993). Two katanin 
subunits, P60 and P80, have been identified. The subunit P60 of katanin which is 
responsible for microtubule severing, encourages shortening processes of mitotic-
meiotic spindle poles and plays an important role in the developing of neuronal 
processes. P80 is thought to target katanin to the centrosome  and enhances the 
microtubule severing capacity of P60 (Hartman et al., 1998).  
This study is subjected to produce monoclonal antibody against P60-katanin, using 
rat sequence based RecP60 (Recombinat P60-katanin) protein as antigen. 
Monoclonal antibodies are produced from hybridoma cell lines which were 
descendant from a single B cell clone are monospecific. Monoclonal antibodies are 
produced unlimitedly hence they have more advantages then polyclonal antibodies. 
So far, P60-Katanin polyclonal antibodies were used in studies until now (McNally 
and Thomas, 1998; Karabay et al., 2004), development of a monoclonal antibody 
against P60, constitute an important resource to monitor the behavior of P60-katanin 
in cells and for the research of P60-katanin's functions.  
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2.  MATERIALS AND METHODS 
2.1 Materials 
2.1.1 Lab equipments 
Centrifuge, Beckman Coulter Allegra 25R 
Ultra centrifuge, Beckman Coulter AvantiTM J-30 I 
Minicentrifuge, Beckman Coulter Microfuge®18 
Magnetic stirrer, Labworld Standard Unit 
pH Meter, Mettler Toledo MP220 
Precision Weigher, Precisa 620C SCS 
Weigher, Precisa BJ 610 C 
Ice machine, Scotsman AF 10 
Vortex, Heidolph, Reaxtop 
Water Baths, Memmert, Elektro-mag M 96 KP 
Thermomixer, Eppendorf Thermomixer Comfort 
Shaker, Forma Orbital Shaker, Thermo Electron Corporation 
Freezers:  
-20oC, Uğur  
+4 oC, Uğur  
-80 oC, New Brunswick Scientific 
UV-Visible Spectrophotometer, UV-1700 (Japan) PharmaSpec Shimadzu 
Pure water system, TKA Wasseraufbereitungssysteme 
Pipettes: 
2.5µl, 10µl, 100µl, 200µl, Eppendorf  
1000µl, Finnpipette Thermo 
Electronic pipette Finnpipette Thermo 
Multichannel (12 channel) pipette, 50-300µl, Genex beta 
Microfuge tubes, 1.5-2ml, Axygen 
Centrifuge tubes, 15-50ml, Avant Plus 
 26 
Autoclave, Tomy SX-700E 
Confocal microscope, TCS SP2 AOBS inverted laser scanning, Leica 
Dialysis tubing cellulose membrane, Sigma 
2.1.1.1 Equipments for Cell Culture 
Laminar air flow cabinets, Faster BH-EN 2003  
CO2 Incubator, Biolab Shel Lab 
Inverted light microscope, Olympus CK40 
Tissue culture plates, 6-12-96 well, TPP 
Tissue culture flasks, 25-75-150cm2, TPP 
Cell Scraper, 30cm length, 20 mm width, TPP 
Hemacytometer, Fisher Scientific 
Syringe filters, 0.22µm, TPP 
Vacuum filtration- system, 150ml, TPP 
Serological pipette, TPP 
Electroporator, Nucleofector Amaxa Biosystems 
Centrifuge, Thermo Electron Corporation IEC CL10 
2.1.1.2 Equipments for ELISA 
ELISA plate washer, Nunc-ImmunoTM Wash 8 
Microplate reader, Bio-Rad Benchmark Plus 3550-UV 
ELISA plates, 96 well, Nunc 
2.1.1.3 Equipments for SDS-PAGE 
SDS-PAGE gel electrophoresis system, Bio-Rad MiniProtean 
Power supply, Thermo Electron Corporation EC250-90 
2.1.1.4 Equipments for Western-blotting 
Mini Blot Module, Thermo Electron Corporation EC140 
Trans-Blot Semi-Dry Electrophoretic Transfer Cell, Bio-Rad 
PVDF membrane, Roche 
Filter Paper, 3MM Whatman 
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2.1.2 Chemicals 
NaH2PO4.2H2O, J.T. Baker 
Na2HPO4, J.T. Baker 
KH2PO4, J.T. Baker 
K2HPO4, J.T. Baker 
NaAc, J.T. Baker 
Glycerol, Fluka 
Acetic acid (glacial), Fluka 
Bradford Reagent, Sigma 
Tween 20 (P9416), Sigma 
Albumine from bovine serum (BSA), Sigma 
Freund’s complete adjuvant, Sigma 
Freund’s incomplete adjuvant, Sigma 
4-Nitrophenyl phosphate di (tris) salt, Sigma 
50% Ni-NTA agarose suspension, Qiagen 
Tris Hydroxymethil aminomethane, BDH Laboratory 
ZnCL2, Riedel- de Haёn 
Acetone, Riedel- de Haёn 
Absolute methanol, Riedel- de Haёn 
Absolute ethanol, Riedel- de Haёn 
Diethyl ether, Lachema 
Glycine, Merck 
Boric acid, Merck 
Glucose, Merck 
Pipes, Sigma 
Hepes, Invitrogen 
EGTA, Sigma 
KCl, Merck 
Imidazole, Merck 
PEG 4000, Merck 
Dithiothreitol (DTT), Merck 
HCl, Merck 
MgCl2.6H2O, Carlo Erba 
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NaCl, Carlo Erba 
Non-fat dry milk, Pınar  
Ammonium Sulphate, Merck 
2.1.2.1  Chemicals for SDS-PAGE 
SeeBlue Plus2 Prestained Protein Ladder, Invitrogen  
Bencmark Prestained Protein Ladder, Fermentas 
TEMED, AppliChem 
2-propanol (Isopropanol), Fluka 
Coomassie Brilliant Blue (CBB) R-2500, Fluka 
N,N’- Dimethyl- bis- Acrylamide, Sigma 
Acrylamide, BDH Laboratory 
Ammonium peroxodisulphate (APS), Merck 
SDS, Merck 
Bromophenol blue, Merck 
2.1.2.2 Chemicals for Bacterial Cell Culture 
Isopropyl-β-D-1-thiogalactopyranosid (IPTG), AppliChem 
Tryptone, Lab M TM 
Kanamycin, Sigma 
Yeast Extract, Merck 
Agar, Merck 
2.1.2.3 Chemicals for Cell Culture 
DMEM- High Glucose- Liquid Media (SH30243), HyClone 
DMEM-High Glucose Powder (D5648), Sigma 
Fetal Bovine Serum (FBS), Biochrom 
Gentamicin, Gibco 
HT Supplement (100X), Gibco 
HAT Supplement (50X), Gibco 
DMSO, Riedel-de Haёn 
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2.1.3 Antibodies 
Anti-Mouse IgG (γ-chain specific)- Alkaline Phosphatase Conjugate antibody 
produced in goat, Sigma 
Anti-Mouse Polyvalent Immunoglobulins (G,A,M)−Alkaline Phosphatase 
Conjugate antibody produced in goat, Sigma 
Chicken anti-GFP Antibody, Aves 
Rabbit anti-β tubulin Antibody, CST 
Anti-mouse IgG Antibody-Alexa 488, Invitrogen 
Anti-mouse IgG Antibody-Alexa 546, Invitrogen 
Anti-mouse IgG Antibody-Cy5,   
Anti-chicken IgY Antibody-FITC, Aves 
Anti-Rabbit IgG Antibody Alexa 647, Invitrogen  
Anti-mouse IgG Antibody-HRP (Horse Radish Peroxidase), Pierce  
Anti-rabbit IgG Antibody-HRP, Pierce 
2.1.4 Commercial kits 
MAbTrap Kit, Sigma 
Endofree Plasmid Maxi Kit, Qiagen 
Nucleofactor Kit VCA-1001, Amaxa 
Supersignal West Femto Maximum Sensitivity Substrate, Pierce  
2.1.5 Buffers and solutions 
2.1.5.1 Buffers for Ni-NTA Affinity Purification 
Lysis Buffer (10 ml) 
NaH2PO4.2H2O  78 mg  
NaCl    175.4 mg  
Imidazole   6.8 mg  
The pH was adjusted to 8.0 with NaOH. 
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Wash Buffer (10 ml) 
NaH2PO4.2H2O  78 mg  
NaCl    175.4 mg  
Imidazole   13.6 mg  
The pH was adjusted to 8.0 with NaOH. 
Elution Buffer (5 ml) 
NaH2PO4.2H2O  39 mg  
NaCl    87.7 mg  
Imidazole   2.72 g  
The pH was adjusted to 8.0 with NaOH. 
2.1.5.2  Buffers for SDS- PAGE  
Acrylamide and N,N’methylene-bis-acrylamide (200 ml) 
 Acrylamide  58,4 g 
 Bis-acrylamide 1,6 g 
 Filter and store at 4oC in the dark. 
 10 % Sodium Dodecyl Sulfate (100 ml) 
 SDS   10 g  
 Filtered and stored at room temperature. 
 0,5 M Tris-Cl Solution (50 ml) 
 Tris    3 g 
 The pH was adjusted to 6,8 with HCl. 
 Filtered and stored at 4oC. 
 1,5 M Tris-Cl Solution (200 ml) 
 Tris    36,3 g 
 The pH was adjusted to 8,8 with HCl. 
 Filtered and stored at 4oC. 
 %10 APS (1ml) 
 APS   0,1 g 
 Stored for 1 week life at 4oC 
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2X Sample Buffer (10 ml) 
 Tris- HCl pH:6.8 (of 0.5 M) 2.5 ml  
SDS (of 10%)    4 ml  
Glycerol (of 100 %)   2 ml  
Bromophenol blue    5 mg 
DTT      231 mg 
Tris-glycine Running Buffer (1 lt) 
0.025 M Tris  3g 
0.192 M Glycine  14.4 g  
0.1 % SDS  10 ml (of 10%) 
Staining Solution (500 ml) 
CBB R-2500  5 g 
Methanol   250 ml 
Acetic acid   50 ml 
Destaining Solution (1 lt) 
Methanol  50 ml 
Acetic acid  100 ml 
2.1.5.3 Buffers for Western-blotting 
Transfering Buffer (150 ml) 
Tris  1,6 g 
Glycine 0,9 g 
Methanol 20 ml   
%10 SDS 800 µl 
Tris-Buffered Saline (TBS) (300ml) 
NaCl  2.4 g 
KCl  0.06 g 
Tris  0.9 g 
The pH was adjusted to 7.4. 
Tris-Buffered Saline -Tween 20 (TTBS) 
Tween 20 (0.05 %) 90 µl 
TBS     180 ml  
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Blocking Solution 
Non-fat dry milk (3 %) 0.9 mg 
TBS    30 ml 
Prepared just before the experiment. 
Primary Antibody Solution I 
Non-fat dry milk (3 %)     0.3 mg 
Hybridoma supernatant     10 ml 
Primary Antibody Solution II 
Non-fat dry milk (3 %)     0.3 mg 
Purified monoclonal antibody (1:1000)   10 µl 
TTBS         10 ml 
Secondary Antibody Solution I 
Anti-mouse polyvalent immunoglobulins-AP (1:5.000) 2 µl 
Non-fat dry milk (3 %)     0.3 mg 
TTBS         10 ml 
Secondary Antibody Solution II 
Anti-mouse IgG-AP (1:10.000)    1 µl 
Non-fat dry milk (3 %)     0.3 mg 
TTBS         10 ml 
BCIP/ NBT Substrate Buffer (250ml)    
MgCl2.6H2O  2,665 g   
Tris   3,03 g    
NaCl   1,46 g 
BCIP/NBT Substrate Solution 
BCIP/NBT stock solution  200 µl  
BCIP/ NBT substrate buffer  10 ml 
The substrate buffer and the stock solution was mixed just before the 
application. 
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2.1.5.4 Buffers for Immunocytochemistry 
 PHEM (2X) (500 ml) 
 Pipes   18,14 g 
 Hepes   5,96 g 
 EGTA  3,8g 
 MgCl2  0,41 g 
 pH was adjusted to 6,9 with NaOH. 
 Made aliquots and stored at -20oC. 
 Gluteraldehyde Fixation/Permeabilization Solution (40 ml) 
Gluteraldehyde (25%) 320µl 
Triton X100 (10%)   400 µl 
Taxol (10 mM)   40µl  
PHEM solution (2X)   20 ml   
Fixative was warmed in 37 0C water bath before using. 
Paraformaldehyde Fixation Solution (25 ml) 
Paraformaldehyde (PFA)  1 gr 
PBS      25 ml 
The pH was adjusted to 7,3 by NaOH. 
The solution was heated to 60oC with stirring overnight. 
Triton X100 Permeabilization Solution 
10% TritonX100 was dilued with PBS into final concentration of 0,2 %. 
Blocking solution (1 ml)  
Goat serum   100 µl  
BSA   10 mg 
PBS    900 µl 
Filtered with 0.8 µm Nalgene filter.  
Stored for 15 days at 4 0C. 
Primary Antibody Solution I (200 µl /dish) 
Hybridoma supernatant 
Centrifuged at 10.000 rpm for 10 minutes at 40C.  
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Primary Antibody Solution II (200 µl /dish) 
Monoclonal Antibody (MAb) (1/1000) 
Filled up to final volume with PBS. 
Centrifuged at 10.000 rpm for 10 minutes at 40C.  
Primary Antibody Solution III (200 µl /dish) 
Chicken anti-GFP (1/1000) 
MAb (1/1000) 
Filled up to final volume with PBS. 
Centrifuged at 10.000 rpm for 10 minutes at 40C.  
Primary Antibody Solution IV (200 µl /dish) 
Rabbit anti-β tubulin (1/500) 
MAb (1/1000) 
Filled up to final volume with PBS. 
Centrifuged at 10.000 rpm for 10 minutes at 40C.  
Secondary Antibody Solution I (200 µl /dish) 
Anti-mouse IgG (Alexa 488/ Alexa 546/ Cy5) (1/1000) 
Filled up to final volume with PBS. 
Centrifuged at 10.000 rpm for 10 minutes at 40C.  
Secondary Antibody Solution II (200 µl /dish) 
Anti-chicken IgY FITC (1/1000) 
Anti-mouse Cy5 (1/500) 
Filled up to final volume with PBS. 
Centrifuged at 10.000 rpm for 10 minutes at 40C.  
Secondary Antibody Solution III (200 µl /dish) 
Anti-Rabbit IgG Alexa 647 (1/1000) 
Anti-mouse IgG Alexa 488 (1/1000) 
Filled up to final volume with PBS. 
Centrifuged at 10.000 rpm for 10 minutes at 40C.  
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2.1.5.5  Buffers for cell culture and ELISA  
Polyethylene Glycol (PEG) solution (2 ml) 
2 g PEG-4000  
Solution was sterilized by autoclave and kept at 37oC. 
PBS   
10 mM KH2PO4 solution: 186 mg/L KH2PO4 
10 mM K2HPO4 solution: 174 mg/L K2HPO4 
10 mM KH2PO4 solution of pH was adjusted to 7.2 with 10 mM K2HPO4. 
0.15 M NaCl was added to final mixture solution. 
PBS-Tween 20  
0.05 % tween 20 was added to PBS buffer. 
Primary Antibody Solution I 
Serum of mouse (1/200) 
Filled up to final volume with PBS. 
Primary Antibody Solution II 
Hybridoma Supernatant 
Secondary Antibody Solution I 
           Anti-Mouse Polyvalent Immunoglobulins (G,A,M)-AP 
Filled up to final volume with PBS. 
Secondary Antibody Solution II 
Anti-Mouse IgG-AP 
Filled up to final volume with PBS. 
Substrate Buffer 
1 mM ZnCl2 
1 mM MgCl2 
0,1 M Glycine 
The pH was adjusted to 10.4 with KOH. 
1 mg/ml 4-paranitrophenylphosphate was added just before using. 
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2.1.6 Bacterial strains 
BL21(DE3)pLysS Escherichia coli strain harbouring pET30a vector with 
cloned P60-katanin  
Genotype: F– dcm ompT hsdS(rB– mB–) gal λ(DE3)[pLysS Camr], 
Novagen 
 DH5α Escherichia coli strain  
Genotype: F-, φ80dlacZ∆M15, ∆(lacZYA-argF)U169, deoR, recA1, 
endA1, hsdR17(rk-, mk+), phoA, supE44, λ-, thi-1, gyrA96, relA1, 
Invitrogen 
2.1.7 Bacterial culture media 
LB medium (1 lt) 
Tryptone  10 g  
Yeast extract  5 g  
NaCl   10 g   
Sterilized by autoclaving at 121oC for 15 minutes. 
34 µg/ml chloramphenicol and 30 µg/ml kanamycin was added. 
LB-agar  
15 g/l of agar to LB medium and sterilized by autoclaving.  
34 µg/ml chloramphenicol and 30 µg/ml kanamycin was added. 
2.1.8 Cell lines 
FO Myeloma, ATCC CRL-1646  
NIH/3T3 Fibroblast, ATCC CRL-1658 
HeLa, ATCC CCL-2 
SHSY-5Y Neuroblastoma, ATCC CRL-2266 
2.1.9 Cell culture media 
Freezing medium 
70 % DMEM 
20 % FCS 
10 % DMSO 
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2.1.9.1 Hybridoma cell culture 
Growth medium 
80 % DMEM (including 3.5 g/L glucose, 2 g/L NaHCO3 and 25 mM Hepes) 
20 % FCS 
50 µg/ml Gentamicin  
HAT medium 
2 % (40ml/L) HAT (50x) was added in growth medium. 
HT medium 
2 % 20ml/L HT (50x) (100X HT) was added in growth medium. 
2.1.9.2 HeLa growth medium 
90 % DMEM (including 3.5 g/L glucose, 2 g/L NaHCO3 and 25 mM Hepes) 
10 % FCS 
20 µg/ml Pen/Strep  
2.1.9.3 Neuroblastoma and Fibroblast growth medium 
90 % DMEM (including 1 g/L glucose, 2 g/L NaHCO3 and 25 mM Hepes) 
10 % FCS 
20 µg/ml Pen/Strep  
2.1.10 Experimental animals 
The 6-8 week old female BALB/c mice were used for immunization and fusion. Rat 
embryos on the day 18 were used for preparing tissue samples for Western- blotting. 
All experimental animal procedures were approved by animal care and use 
committee (Appendix A). 
2.1.11 P60-katanin construct 
pEGFP-C1 (Invitrogen) vector with full length P60-Katanin.  
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2.2 Methods 
2.2.1 Antigen preparation 
2.2.1.1  Recombinant P60-katanin expression induction 
• Frozen glycerol stock of BL21(DE3)pLysS colonies harbouring pET30a 
vector with cloned P60-katanin was spread on LB-agar petri plates.  
• Single colony from the plate was inoculated into 5 ml LB and left for 
overnight at vigorous shaking at 37°C.  
• Next day, 5 ml of overnight culture was diluted with 500 ml LB media and 
was incubated with shaking at 37°C.  
• After OD600 reached 0.6-0.8, 2ml cell culture was collected for uninduced 
total and soluble-unsoluble protein analysis and total culture was induced 
with 0,5 mM IPTG and grown for 12 hours, taking 2 ml culture samples at 
4th, 8th and 12th hours.  
• Total cell culture was centrifuged for 5 minutes at 14000 x g at 12. hour after 
induction and Ni-NTA affinity chromatography was applied. 
2.2.1.2  Total protein analysis of the cell 
• After induction, collected 1 ml cell cultures at 4th, 8th and 12th hours were 
centrifuged for 5 minutes at 14000 x g .  
• Pellet was mixed with 50 µl  2X SDS sample buffer and stored at 4°C until 
SDS-PAGE analyses. 
2.2.1.3 Soluble-unsoluble total protein analysis of the cell 
• After induction, collected 1 ml cell cultures at 4th, 8th and 12th hours were 
centrifuged for 5 minutes at 14000 x g . 
• Pellet was resuspended in 1 ml of ice-cold 20 mM Tris-HCl pH 7.5.    
• Suspension was incubated at -80°C until SDS-PAGE analyses.  
• On the day of SDS-PAGE, they were thawed on ice and centrifuged at 14,000 
× g  for 10 minutes. 
• The pellet which would give the unsoluble fraction was resuspended with 10 
ml lysis buffer. 
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• The supernatant which would give the soluble fraction, was concentrated with 
TCA (trichloracetic acid) method:  
- 100 µl (1/10 volume) of 100% TCA (w/v) was added to 1 ml of 
supernatant, vortexed and placed on ice for 15 minutes.  
- Centrifuged at 14000 x g for 10 minutes.  
- Pellet was washed with 100 µl of acetone, vortexed and centrifuged at 
14,000 × g for 5 minutes. This step was done twice. 
- Pellet was allowed to air dry. 
2.2.1.4 Protein separation by SDS-polyacrylamide gel electrophoresis  
To analyse total and soluble-unsoluble proteins and to separate proteins by size, 
sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) was 
performed.  
• Firstly, 12.5 % separating gel was prepared: 
2,08 ml  30 % acrylamide 
1,25 ml 1,5M Tris, pH 8.8 
1,56 ml dH2O 
50 µl  10 % SDS 
30 µl  10 % APS 
10 µl   TEMED 
The solution was applied into the gel cassette and isopropanol was added 
drop by drop onto the gel. After polymerization isopropanol was carefully 
removed. 
• 5% stacking gel was prepared. 
0,33 ml 30 % acrylamide 
0,25 ml 1 M Tris, pH 6.8 
1,38 ml  dH2O 
20 µl  10 % SDS 
10 µl  10 % APS 
5 µl   TEMED 
The stacking gel solution was poured into the gel cassette, and the gel comb 
was placed.  
• After polymerization the comb was removed and the gel cassette was set into 
the PAGE apparatus and filled with Tris-glycine running buffer. 
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• The samples containing proteins were prepared: 
- Samples were resuspended in 2X sample buffer and denaturated for 5 
minutes at 95ºC  
- 7.5 µl of each sample was loaded on the SDS PAGE gel.  
• The proteins were run in the stacking gel for 15 min at 150 V, 250 mA, 25 W  
• When the proteins passed through the separating gel, they were separated for 
105 min at 100 V, 250 mA, 25 W. 
• SDS-PAGE was stained in staining solution for overnight at room 
temperature and destained in destain solution at 65oC for 30 minutes with 
shaking at 50 rpm. 
2.2.1.5 Metal affinity purification of 6xHis tagged RecP60 
The NI-NTA (nickel-nitriloacetic acid) affinity purification uses the interaction 
between nickel (or other metal ion, e.g. copper, zinc, cobalt) and imidazole ring to 
purify His-tagged proteins. When the lysate of the cell culture is mixed with Ni-NTA 
agarose, nickel binds imidazole ring structure of histidine. To elute histidine tagged 
protein, highly concentrated imidazole which replace with histidine is used.  
Purification of RecP60 was performed under native conditions.  
• After induction with IPTG, 500 ml bacterial culture was centrifuged for 5 
minutes at 14000 x g.  
• The pellet was stored frozen at -80oC until the next step was done.  
• The frozen pellet was thawed on ice, resuspended in 5 ml lysis buffer and 
centrifuged  for 10 minutes at 14000 x g.    
• 500 µl of 50 % Ni-NTA agarose was added to the supernatant and gently 
mixed for 1 hour at 4oC.   
• Short spin was done to pellet the resin.  
- Supernatant (flow-through) was collected to analyse the unbound protein 
in SDS-PAGE.  
• The resin was washed three times with 2,5 ml of wash buffer. Short spin was 
done after each wash step. 
- Supernatant was collected to analyse in the SDS-PAGE, if the unbound 
protein was removed totally.  
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• Finally, 250 µl elution buffer was added, short spin was done and supernatant 
containing purified protein was taken to a fresh tube and stored at -20ºC. This 
step is done for 4 times. 
2.2.1.6 Bradford analysis for purified RecP60  
The Bradford assay is based on the formation of a complex between the dye, Brilliant 
Blue G, and proteins in solution. The protein-dye complex causes a shift in the 
absorption maximum at 595 nm. In order to determine the concentration of purified 
P60-katanin 96 well plate assay protocol was applied. This assay is performed in a 96 
well plate. It is possible to quickly assay multiple protein samples with this assay, 
while using a small sample volume (5 µl of a 0.1-1.4 mg/ml protein sample is used). 
• BSA standard ranging from 20 µg -1,25 µg/20µl was prepared in PBS and 
distributed to wells in the 96 well plate.  
• P60 elution samples were prepared at different dilutions by PBS with an 
approximate concentration between 20 µg -1,25 µg/20µl and distributed to 
wells.  
• 200 µl of the bradford reagent was added onto each well and mixed on a 
shaker and incubated at room temperature for 5 minutes.  
• Absorbance was measured at 595 nm. 
2.2.2 Immunizing mice with purified RecP60 and screening antibody sesponse 
by ELISA 
BALB/c female mice were immunized two times intraperitoneally with 50 µg of 
RecP60/mouse. At first immunization, P60 was injected with Freund’s complete 
adjuvant and at the second immunization, P60 was injected with Freund’s incomplete 
adjuvant. After immunization anti-P60 antibody response was assayed by indirect 
ELISA which is described in the following steps: 
• 120ng P60/well was coated on ELISA plate and incubated for overnight at 
4oC. 
• Washing: The plate was washed with PBS-Tween-20, 3 times by using 
microplate washer. 
• Incubation: The plate was blocked with %1 milk powder and incubated at 
37oC for 1 hour. 
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• The plate was washed as explained at the above step 
• Serum of P60 immunized mice at 1/200 dilution or hybridoma supernatants 
were treatened onto plates and incubated as the above step. 
• The plate was washed. 
• Polyclonal antibody response was screened by adding 1/1000 diluted alkaline 
phosphatase conjugated anti-mouse polyvalent immunoglobulins (conjugate) 
and IgG antibody response was screened by adding 1/2000 diluted alkaline 
phosphatase conjugated anti-mouse IgG and incubated. 
• The plate was washed five times.  
• Conjugate-antiserum reaction was monitored by detection of p-nitrophenyl 
phosphate hydrolysis reaction which could be understood by appearance of a 
yellow color. p-nitrophenyl phosphate was added onto wells and after 1 hour 
incubation at the dark, the optical density at 450 nm was read by microplate 
reader.  
2.2.3 Cell culture studies 
2.2.3.1 Thawing cells from -80oC storage 
Cells which had been stored in -80oC  for at most 6 months were thawed in 37oC 
water bath and taken into 10 ml PBS buffer for centrifugation for 5 minutes at 900 x 
g. Cell pellet was dissolved with growth medium and transferred to the culture flasks. 
2.2.3.2 Counting cells 
Cell pellet was suspended with 20 ml PBS. Then 10 µl suspension was taken and 
dispersed on the hemacytometer, cells were counted as the number of cells per 25 
square (1mm2). Total cell number was calculated by the two formula, given below:  
104 (constant number)   x   Amount of Counted Cell  =  Cell Number/ml (2.1) 
Cell Number/ml   x   Volume of Cells (ml)  =  Total cell number   (2.2) 
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2.2.3.3 Cell passage 
Growth medium of cells was removed and 10-15 ml PBS was added in their growing 
75 cm2 flasks. FO and hybridoma cells that attach on the culture dish were lifted via 
cell scraper and the cells are suspended.  
For HeLa, NIH/3T3 Fibroblast, SHSY-5Y Neuroblastoma cells to detach from the 
culture dish and make the cell suspension several steps were performed. PBS was 
removed from the flask and 1 ml Trypsin/EDTA was added. Flasks were placed in 
CO2 free incubator for 2 minutes. Flask was smacked couple of times, to make cells 
flow freely. 
Suspended cells were put into the centrifuge tubes and centrifuged at 900 x g for 2 
minutes. Centrifugation step was repeated two times. The cell pellet was resuspended 
with fresh medium and divided into additional flasks. 
2.2.3.4 Cell freezing  
After the cell passage, cells were taken into the centrifuge tubes and they were 
washed with PBS. The cell pellet was transferred to freezing tubes with freezing 
medium for stocking them. Estimated cell number per freezing tube was 2x106 
cell/ml. 
2.2.4 Hybridoma Technology 
2.2.4.1 Preparation of feeder cells 
Feeder cells were isolated from the unimmunized, normal mouse a day before the 
fusion. After the mouse was sacrificed by cervical dislocation method and 
disinfected in 70 % alcohol, was taken into laminar flow and placed on the dissecting 
board in the dorsal position. Abdomen skin of mouse was separated from the 
underlying peritoneum. To obtain feeding cell (macrophage) mixture from the 
peritoneum internal face, 5 ml DMEM was injected into the peritoneum cavity and 
taken back. The mixture was taken to the sterile tube and the cell number was 
counted. ~6000 feeder cell/100µl was transferred to each well of the cell culture plate 
which would be used for growing hybridomas after fusion.  
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2.2.4.2 Isolating spleen and lymph node cells from immunized mouse 
Among the mice having the highest immune response was selected by indirect- 
ELISA and was sacrificed by cervical dislocation method. The mouse was sterilized 
with 70 % ethanol and taken into laminar flow. The animal was laid on its backside 
on the dissecting board. With the sterile scissors, incision was made started from 
genital region to inferior chin and the skin was flayed laterally on two sides. Four 
pairs of cervical superficial, one pair of axillary, brachial, inguinal and sciatic lymph 
nodes which are the superficial were collected. When the incision was made in the 
peritoneal wall, several nodes of mesenteric and two pairs of lumbar which were 
deep lymph nodes were collected (Figure 2.1). On the left side, spleen was pulled 
gently, any connective tissue was removed using the blunt end of the sterile forceps 
and removed from the body. As two groups spleen tissue and lymph nodes were put 
into petri dishes separately, containing 5 ml PBS in order to purify it from the fatty 
tissues.  
 
Figure 2.1 : Scheme reporting localization of the lymphatic system.  
 
The isolated tissues were teased in metal mesh by sequeezing with a glass tube to 
reveale cells. Cells were suspended in the petri and washed 2 times with 20 ml PBS 
Superficial lymph nodes (yellow) deep lymph nodes (orange) and spleen (pink)  
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buffer by centrifugation at 900 x g for 5-10 minutes. Pellet was dissolved in 10 ml 
medium and  cells were counted.  
2.2.4.3 Preparation of myeloma cells 
10 days before fusion, FO myeloma cells were started to be cultivated in growth 
medium. At the beginning of the myeloma cell culture studies, 20 µg/ml azoguanin 
was added to the medium to eliminate HGPRT (+) mutant cells. In the fusion day, 
myeloma cells were removed from the flasks by making passage and cells were 
washed 2 times with PBS buffer by centrifugation at 900  x g for 5 min. Pellet was 
taken into 20 ml medium and cells were counted. Cell mixture was held in 5 % CO2  
incubator while preparing spleen cells and lymph nodes for fusion. 
2.2.4.4 Fusion 
Myeloma/spleen and myeloma/lymph cells were combined in proportion to 1/10-1/2 
and centrifuged at 900 x g for 10 minutes. After the centrifugation, supernatants were 
removed. 1 ml (for spleen cells) and 500 µl (for lymph cells) PEG-4000 which was 
heated at 37oC was added to the pellet of cell mixture drop by drop within 1 min. and 
mixed gently for 1 minutes. 4 ml (for spleen cells) and 2 ml (for lymph cells) DMEM 
was added within 1 minutes. 20 ml (for spleen cells) and 10 ml (for lymph cells) 
DMEM was added within 2 minutes. Finally, 20 ml (for spleen cells) and 10 ml (for 
lymph cells) DMEM that contains 15 % FBS was added within 2 minutes. Mixture 
was held for one hour at 37oC in 5 % CO2 incubator and they were taken to the 
centrifuge at 800 x g for 5 min. After the centrifugation, pellet was suspended with 
HAT medium and dispersed as 150 µl/well to the cell culture plates which contained 
feeder cells, prepared one day before the fusion.  
2.2.4.5 Following culture after fusion 
 6-10 days after the fusion, medium of 100 µl/well was removed from the cell culture 
plates and fresh HAT medium was added as 100 µl/well. 14 days after the fusion, the 
culture medium was changed with HT medium with the same method. Growing 
medium was applied according to the period of cells’ growth. In 6-10 days period, 
cells have big and clear images and some small hybridoma colonies can be observed. 
Each cell culture well was screened by light microscope in order to find out wells 
including colonies that would be tested by indirect ELISA. 
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2.2.4.6 Subcloning and large scale production of hybrid cells  
Subcloning is required to make the hybridoma cell line coming from the offspring of 
the single hybridoma cell which results monospecific monoclonal antibody secretion. 
The procedure involves distributing the hybridoma cell suspension with graded 
dilutions which results one cell per well in the cell culture plate and the method is 
called limited dilution (Liddell and Cryer, 1991). This method removes other kinds 
of antibody producing and nonproducing cells that avoids the suppression of the one 
kind of antibody producing cells when they overgrow in the culture.  
The limiting dilution method was repeated at least 3 times and searched for antibody 
producing hybrid wells which grew in the last limiting dilution step. The cells from 
the selected hybrid well were cultured and stored frozen.  
Hybrids were transferred to the different size culture flasks to have high amount of 
antibody yield. For that reason, hybrids were cultivated in 25 cm2 and 75 cm2 culture 
flasks. After cell growing, supernatants containing desired antibody were collected in 
tubes. 
2.2.5 Characterization of anti-RecP60 monoclonal antibodies 
Obtained monoclonal antibodies against RecP60 katanin (antigen) were screened if 
they recognize P60-katanin at tissues by Western-blotting and in mitotic cells by 
immunocytochemistry. 
2.2.5.1 Western-blotting 
Western-blotting procedures involve the transfering of proteins that have been 
separated by gel electrophoresis onto a membrane, followed by immunological 
detection. For immunoblotting analysis HeLa, NIH/3T3 Fibroblast, SHSY-5Y 
Neuroblastoma cells and brain, liver, lung and heart lysates of embryo and adult of 
rats were applied to 12,5 % SDS-PAGE.  
Sample Preparation 
Cells were detached from the flasks and  tissues were isolated from rats , they were 
washed twice in ice cold PBS and homogenized in 2X  Laemmli sample buffer and 
denaturated for 5 minutes at 95ºC.  
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SDS-PAGE 
50 µg samples were loaded on the SDS-PAGE gel and run in the stacking gel for 15 
minutes at 150 V, 250 mA, 25 W and when the sample passed through the separating 
gel, they were separated for 105 minutes at 100 V, 250 mA, 25 W until the dye of 
sample buffer migrate to the bottom end of the gel. 
Transfer 
In this step the separated proteins in the gel were electrophoretically transferred to 
PVDF membrane. 
• The PVDF membrane was prepared for transferring, soaked in methanol, washed 
with dH2O and kept in transfer buffer for 10 minutes. 
• The gel was placed in the “sandwich” chamber with 6 filter papers and prepared 
PVDF membrane (3 filter paper/gel/PVDF membrane/3 filter paper) all soaked in 
transfer buffer. 
• The trans-blot was run at 20 V for 30 minutes. 
Immunologic detection 
For immunological detection two types of antibodies are utilized. The primary 
antibody is directed against the target protein. The secondary antibody is specific for 
the constant region of the primary antibody and it is conjugated to an enzyme such as 
alkaline phosphatase (AP) or horseradish peroxidase (HRP). Anti-mouse IgG or 
Anti-mouse polyvalent was used as secondary antibody. Two kinds of detection 
method were used. In chromogenic detection, BCIP/NBT substrate was used to 
visualize AP cojugated antibody binding and in chemiluminescant detection, luminol 
substrate (super signal substrate kit) was used to visualize HRP cojugated antibody 
binding.  
• The membrane was incubated with blocking solution by shaking for 2 hours at 
room temperature. 
• It was washed for 10 minutes with TTBS solution, 3 times. 
• The membrane was incubated with primary antibody solution by shaking 
overnight at 4oC. 
• The membrane was washed as explained at the above step.  
• The membrane was incubated with secondary antibody solution for 1 hour at 
room temperature. 
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• The membrane was washed twice with TTBS for 10 minutes and once with TBS 
for 10 minutes. 
• Finally, membrane was soaked into NBT/BCIP substrate solution and kept in the 
dark until the bands were observed for chromogenic detection.  
• The reaction was stopped by washing the membrane with dH2O and it was dried 
at room temperature in the dark.  
• For chemiluminescent detection, immunoreactive bands were monitored by 
incubation of the membrane with supersignal west femto kit including luminol 
enhancer with peroxidase solution for 5 minutes in the dark and analyzed with 
CCD camera by UV exitation. 
2.2.5.2 Purification of monoclonal antibodies 
In order to store the obtained monoclonal antibody (1G6) in large amounts and to use 
for a long time, it is needed to be concentrated and purified. Therefore, purified 
antibody can be examined in large amounts that is needed in performing 
characterization methods and the antibody’s affinity in different range of 
concentrations can also be monitored.  
Protein precipitation of hybridoma  supernatants by ammonium sulphate 
45 % Ammonium sulphate was added to 100 ml of cultured 3H4 and 1G6 hybridoma 
cell supernatants,  in 30 minutes and mixed overnight at 4oC. The mixture was 
centrifuged at 20.000 x g, 1 hour, at 4oC. Pellet was dissolved in PBS and dialised 
against PBS two times, overnight. 
Protein-G Immuno-affinity Column Chromatography 
Protein-G column was used to purify monoclonal antibodies from  concentrated 
proteins of cell culture medium. Column was washed with 5 ml dH2O and 4 ml of 
binding buffer. Ammonium sulfate precipitated and dialized medium was filtered and 
loaded on the column and binding buffer was added to the column. 1 ml of fractions 
were collected and absorbance was measured at 280 nm. Binding buffer was 
transfered from the column until the absorbance of fractions were zero and elution 
buffer was applied. Eluted fractions were collected as 0,5 ml in 50 µl neutrilizing 
buffer containing tubes. After absorbance at 280 nm became zero, 5 ml binding 
buffer and 2 ml ethanol was loaded to store the column. Collected column fractions 
were tested by ELISA to select the eluted antibody fractions by its activity. 
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2.2.5.3 Immunocytochemistry with monoclonal antibodies  
HeLa (human), SHSY-5Y Neuroblastoma (human) and NIH/3T3 Fibroblast (mouse) 
cells were grown on coverslips in 33 mm cell culture petri plates for 48 hours in 
growth medium. The cells were fixed and permeabilized with methanol and they 
were treated with IgG type of monoclonal antibodies (MAbs), 1G6, 3H4, 3H6, 9H3. 
To visualize these MAbs’ recognition of intrinsic P60-katanin, cells were incubated 
with flourescence labelled secondary anti-mouse IgG antibodies (Alexa 488; Alexa 
546 or Cy5). Paraphormaldehyde, gluteraldehyde and methanol fixation methods 
were tried to find out the optimum method for our antibody stainings. MAbs were 
examined with their supernatant and also with their purified forms. Since 1G6 was 
found to interact with P60-katanin in all fixation methods, to further confirm the  
localizations, overlay of P60-katanin and tubulin was analyzed on methanol fixed 
HeLa cells. 1G6 and rabbit anti-β tubulin antibody were used as primary and Alexa-
488 anti-mouse IgG and Alexa-647 anti-rabbit IgG antibody were used as secondary 
antibodies. 
Fixation-Permeabilization of cells by Gluteraldehyde  
• The fixation/extraction solution was warmed at 370C water bath.  
• Petri dishes containing the cultured cells were filled with 2 ml of fixation/ 
permeabilization solution and incubated at room temperature for 15 minutes. 
• 10 mg/ml sodium borohydrate solution was prepared in PBS.  
• Cells were quenched 2 times for 15 minutes with sodium borohydrate 
solution then rinsed with PBS 3 times for 5 minutes. 
• Dishes were kept in 4 0C until the day of immunostaining in PBS. 
Fixation-Permeabilization of cells by Methanol  
• MeOH was placed at -20 0C in beaker for 10 minutes to be chilled. 
• The media from the dishes containing the cultured cells were removed and 
filled with ice-cold MeOH and kept for 15 minutes. 
• MeOH was removed from the dishes. 
• The dishes were rinsed with PBS 3 times and kept at 40C until the day of 
immunostaining in PBS. 
Fixation of cells by Paraformaldehyde and Permeabilization by TritonX100 
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• The paraformaldehyde fixation solution was warmed at 370C and filtered. 
• The cell were fixed with the solution for 15 minutes at room temperature. 
• For permeabilization, the dishes were filled with 2 ml of TritonX100 solution 
and kept for 10 minutes at room temperature. 
• Cells were rinsed with PBS 3 times for 5 minutes. 
• 10 mg/ml sodium borohydrate solution was added to cells and quenched two 
times for 15 minutes. 
• Cells were rinsed with PBS and kept at 4 0C until the day of immunostaining. 
Immunostaining 
• Fixed cells were blocked for 1 hour at room temperature with 150 µl blocking 
solution.  
• Blocking solution was removed carefully and 150 µl primary (1o) antibody 
(Ab) solution was put on. 
• 1o Ab containing cells were incubated at 40C, overnight. During this staining 
period, the dishes were placed in a “humidified chamber,” a large petri dish 
containing moistened filter paper, which minimizes evaporation of the 
antibody.   
• 1o Ab was removed and dishes were washed by using PBS 3 times for 5 
minutes.  
• Cells were blocked again for 1 hour at room temperature. 
• Secondary (2o) Ab solution was prepared and centrifuged in the same way as 
1o Ab and 150 µl of 2o Ab solution was applied to the dishes. 
• Cells were incubated for 1 hour at 37 0C incubator in the dark. 
• All the dishes were rinsed with PBS 3 times for 5 minutes each. 
• 20 µl of mounting medium was added and cover slips were placed on the 
dishes. 
• Coverslips were fixed from the edges by using nail polisher. 
• Dishes were visualizes and analyzed by using confocal microscopy. 
2.2.5.4 Overexpression of P60-Katanin in mitotic cells 
For overexpression of the katanin,  HeLa cells were transfected with the pEGFP-C1 
vector (Clontech, Mountain View, CA) carrying full P60-katanin (human). Firstly, 
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the constructs were transformed into competent DH5α E.Coli bacterial strain for 
copying (replicating) them in large scale. It is aimed to concentrate the amount of  
the plasmid because it is prerequisite for eukaryotic transfection. The plasmids were 
purified from the transformed and large scale cultured cells so the concentrated 
amount would be obtained. The consruct that was produced and purified in large 
amounts were transfected into HeLa cells. 
Transformation of P60-pEGFP-C1 into DH5α 
• The competent DH5α cells were taken from –80oC and thawed on ice.  
• When cells were thawed on ice, 1 µl of P60-katanin construct was added 
immediately to 50 µl of competent cells and the mixture was incubated on ice for 
30 minutes. 
• Then, heat shock was done by putting the cells in the 42oC waterbath for 45 
seconds and they were then immediately put back on ice for 3 minutes.  
• 100 µl of SOC medium was added to treated cell-plasmid mixture and short 
cultured at 37oC for 1 hour by shaking at 200 rpm,.  
• 100 µl of cells were then spreaded onto LB-agar plate containing 30µg/ml 
kanamycin. The plates were incubated at 37oC overnight. 
Large-Scale Purification of P60-pEGFP-C1 
Endotoxin-free DNA will improve transfection into sensitive eukaryotic cells. 
Therefore, in this step EndoFree Plasmid Maxi Kit was used for obtaining endotoxin-
free plasmid DNA. 
• Starter culture: A single bacterial colony was picked from the cultured 
transformation plate and inoculated into 5 ml LB media with kanamycin and 
incubated for 6 hours with shaking at 200 rpm, at 37ºC.  
• 200 µl of the starter culture was diluted into 100 ml LB media with 
kanamycin and incubated for overnight with shaking at 200 rpm, at 37ºC.  
• The next day, 50 ml of the culture was distributed into 2 falcon tubes and 
centrifuged for 30 minutes at 6000 x g.  
• The supernatants were discarded completely and the bacterial pellet was 
resuspended in 10 ml of suspension buffer (5ml/falcon) and collected to one 
of the falcon tubes. 
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• 10 ml lysis buffer was added and mixed by vigorously inverting the tube 6 
times and incubated at room temperature for 5 minutes.   
• Cell lysate was precipitated by addition of 10 ml chilled neutralization buffer 
and the tube was again mixed as told at the above step. 
• The lysate poured into the barrel of the cartidge and incubated at room 
temperature for 10 minutes. 
• The cap from the cartridge outlet nozzle was removed and the plunger was 
inserted into it and cell lysate was filtered and collected into a falcon tube.  
• 2,5 ml endotoxin removal buffer was added to the lysate and mixed by 
inverting the tube 10 times and incubated on ice for 30 minutes. 
• Qiagen column was equilibrated by adding 10 ml equilibration buffer, 
allowing the column to empty by gravity flow. 
• The endotoxin removal buffer added lysate was applied to the equilibrated 
column and allowed to enter the resin by gravity flow.  
• The filter was washed 2 times with 30 ml washing buffer. 
• The plasmid was eluted by passing 15 ml elution buffer which was previously 
warmed at 40oC, through the washed filter. The eluate was collected in a 
polystyrene or polypropylene falcon tube. 
• The eluted DNA was precipitated by adding 10,5 ml (0,7 volumes) room-
temperature isopropanol. The mixture was centrifuged immediately at 3600 x 
g for 60 minutes at 4°C. The supernatant was decanted. 
• The DNA pellet was washed with 5 ml of endotoxin-free 70 % ethanol at 
room temperature and centrifuged at 3600 x g for 60 minutes at 4°C. The 
supernatant was decanted carefully, without disturbing the pellet. 
• The pellet was air-dried for 15 minutes, and redissolved in 200 µl of 
endotoxin-free Buffer TE. 
• Concentration of the purified plasmid was determined by UV 
spectrophotometry at 260 nm. Its migration was analysed in agarose gel 
electrophoresis. Absorbance at 260 nm was used to calculate the obtained 
amount of the plasmid by comparing and proportioning with the standard 
plasmid. 
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Transfection of  purified P60-pEGFP-C1 into HeLa Cells 
• 15 µg of P60-katanin pEGFP-C1 construct was put into tube.  
• Cultured cells were detached and counted with hemacytometer.  
• 1x106 cells/transfection were taken from the cell suspension and centrifuged 
at 900 x g for 5 minutes. 
• Supernatant was removed and the cell pellet was resuspended with 100 µl 
solution R (Amaxa nucleofactor kit). 
• Cell-solution R suspension was put into each tube containing plasmids and 
mixed. 
• The mixture was transferred into the electroporation cuvette (Amaxa) and 
placed into electroporator.  
• The transfection was done in the nucleofector instrument by using the 
program I-013.  
• Electroporated cells were taken out immediately by special pipettes provided 
in the nucleofactor kit and transferred into new tubes containing 900 µl fresh 
medium. As a result we had 106 cells/ml that means ~1x106 cells per 
transfection set. 
• 10.000 cells/dish were plated into 33 mm plastic culture dishes. Hence, for 5 
dishes 10.000 cells x 5 = 50.000 cells were needed which was in 50 µl. 50 µl 
of transfected cells were suspended in 700 µl medium and plated as 150 
µl/dish. 
• Cells were put  in 37 0C 5% CO2 incubator for 2-3 hours. 
• 2 ml warm medium was added into the dishes and cells were cultured at 370C 
5% CO2 incubator.  
After electroporation, cells were fixed-permeabilized with methanol at 4th, 8th, 12th, 
24th, 48th and 72th hours to determine different expression levels of P60-GFP  and 
then treated with 1G6 MAb and chicken anti-GFP antibody. Cy5 conjugated anti-
mouse and FITC conjugated anti-chicken IgY antibodies were used as secondary 
antibodies, respectively. Images of the cells were obtained with a TCS SP2 AOBS 
inverted laser scanning confocal microscope (Leica, Wetzlar, Germany) using a 63x 
oil immersion objective.  
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3.  RESULTS 
Production of monoclonal antibody against P60-katanin studies have been performed 
in four steps. The first step was cloning the selected RecP60 sequence performed in 
Karabay’s laboratory previous to the study. For  the second step, the antigen which 
named recombinant P60-katanin (RecP60) has been expressed in large scale. For the 
third step monoclonal antibodies against RecP60 were produced by hybridoma 
technology. For the fourth step the monoclonal antibodies were characterized by 
Western-blotting and immunocytochemistry. When the study was concluded one 
antibody named 1G6 was selected as monoclonal antibody recognizing P60-Katanin. 
3.1 Preparation of RecP60 Protein As The Antigen 
3.1.1 Optimization of large scale RecP60 expression time 
RecP60 which was inserted in pET30a vector was expressed in BL-21(DE3)pLysS 
cells under 0,5 mM IPTG induction. After induction, culture samples were collected 
at 4th , 8th  and 12th hours in order to determine the maximal soluble amount of 
RecP60 expression time for large scale production. In order to check whether over-
expressed P60-katanin was in the soluble fraction, cells were disrupted by freezing 
and thawing. Soluble and insoluble fractions were separated by centrifugation after 
they were suspended in Tris buffer. The supernatant which was the soluble fraction, 
was concentrated by TCA method and these samples were compared with total cell 
protein samples by SDS-PAGE.  
The SDS-PAGE results showed that RecP60 was expressed at 35 kDa and found in 
maximal amount at the soluble fraction of 12th hour of IPTG induction. Beginning 
from the 4th hour, the amount of soluble RecP60 seemed to increase proportionally to 
the amount of total cell protein and became distinguishable in a maximum level at 
12th hour after IPTG induction. In the uninduced control sample any distinguishable 
overexpressed protein was not found (Figure 3.1). Amount of soluble protein seems 
to increase proportionally to the amount of total protein. Studies of soluble and 
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insoluble fractions showed that most of the expressed protein is in soluble state 
means that the His tagged protein was purified in soluble state succesfully under 
native conditions.   
 
Figure 3.1 : SDS-PAGE analysis of the expression level and soluble proportion of   
RecP60. 
 
 
 
 
Figure 3.2 : SDS-PAGE analysis of RecP60 purification by Ni-NTA affinity.  
 
 
P60 is seen in total and soluble protein fractions which is shown with arrows. 
Uninduced total protein (Uin.t.), Induction after 4h. total protein (In.4.t), 
Induction after 4h. soluble protein (4.sol), Induction after 4h. unsoluble 
protein (4.usol), Induction after 8h. total protein (8.t.), Induction after 8h. 
soluble protein (8.sol.), Induction after 8h. unsoluble protein (8.usol), 
Induction after 12h. total protein (12.t), Induction after 12h. soluble protein 
(12.sol), Induction after 12h. unsoluble protein (12.usol.) 
 
Purified P60 is shown with arrows. Flow through (FT), First wash fraction 
(W1), Second wash fraction (W2), M:  Benchmark prestained protein ladder, 
First elution fraction (E1), Second elution fraction (E2), Third elution 
fraction (E3), Forth elution fraction (E4), Uninduced soluble protein 
(Uin.Sol.) 
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3.1.2 Expression and purification of RecP60 under native conditions 
As the RecP60 nucleotide sequence was cloned into pET30a vector, it was expressed 
as a fusion protein with His-Tag sequence. Since studies of soluble and insoluble 
fractions showed that most of the expressed RecP60 was in soluble form at 12th hour 
of induction, the pellet of large scale culture induced for 12 hours was collected. 
RecP60 was purified by Ni-NTA agarose purification method under native 
conditions, using the affinity of the His-Tag sequence to Ni. 
The lysate of 12th hour culture was treated with Ni-NTA agarose. After washing step, 
RecP60 was eluted. The fractions of each purification step were analysed with SDS-
PAGE (Figure 3.2). A very dense protein band was seen in the 1st elution fraction 
clearly and as expectedly in the following elution fractions the protein amount 
decreased gradually. The absence of RecP60 in flow-through and wash fractions 
showed that RecP60 was captured by Ni-NTA agarose. Uninduced culture was also 
applied to the SDS-PAGE as the negative control. It was clearly seen that 
overexpressed band was only observed in purified, induced pET30a-P60 transformed 
fractions, missing in the negative sample.   
3.1.3 Measurement of purified RecP60 concentration by Bradford Assay 
The protein concentrations of each RecP60 purified fractions were measured by 
Bradford reagent. At the first stage of the application standard curve was drawn by 
using BSA prepared at different concentrations as standarts and the measurement of 
the absorbance at 595 nm of the standards with Bradford reagent (Figure 3.3). 
RecP60 elution fractions were prepared by serial dilutions and their absorbance at 
595 nm was measured (Figure 3.4).  
To calculate the protein concentration of RecP60 elution fractions, increasing 
micrograms of BSA standard absorbtions were compared with the absorbtions of 
elution fractions at increasing volumes. The absorbance of the certain volume of each 
fraction  was  spotted on the standard curve and the corresponding concentration was 
revealed   on   the   same   curve.   If   4 µl   of   each   fraction   was  considered,  the  
concentrations were calculated as follows: E1, 20 µg/4µl (5 mg/ml); E2, 10µg/4µl 
(2,5 mg/ml); E3, 3.5 µg/4µl (875 µg/ml); E4, 1.5 µg/4µl (375 µg/ml).  
 
 58 
 
BSA standart with Bradford Assay
1,25; 0,482
2,5; 0,621
5; 0,743
10; 0,91
20; 1,063
y = 0,2093Ln(x) + 0,4269
R2 = 0,9972
0,2
0,4
0,6
0,8
1
1,2
0 5 10 15 20 25
µg
OD
 
59
5
 
Figure 3.3 : BSA standart curve of the Bradford assay. 
 
 
Figure 3.4 : Results of the bradford assay of RecP60 purified fractions. 
 
 
 
The fractions were collected as 250 µl in the purification step, so from the 1st  
fraction of elution (E1) to the 4th fraction (E4), 1250 µg/250µl, 625 µg/250µl, 
219 µg/250µl, 94 µg/250µl RecP60 protein was obtained, respectively. As a result, 
2,2 mg/ml RecP60 protein was in total purified with Ni-NTA purification method. 
The graph shows absorbtions at 595nm of purified RecP60 at increasing 
volumes. Purified fractions:  First elution fraction; E1, Second elution 
fraction; E2, Third elution fraction; E3, Forth elution fraction;E4. 
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3.2 Monoclonal Antibody Production 
3.2.1 Immune response control of mice and determining RecP60 coating amount 
for ELISA 
Anti-RecP60 polyvalent and anti-RecP60 IgG antibody response of BALB/c mice 
immunized with RecP60, were assayed by ELISA. For the first ELISA test, it was 
necessary to find the optimum coating amount of RecP60 on ELISA plates. 
Therefore, the immune sera of mice were treated with the coated various amounts of 
(30, 60, 120 ng/well) RecP60 during the ELISA. Immune response against RecP60 
was controlled by using two types of secondary antibody. Polyvalent response which 
would indicate the three types of antibody response was analysed by using alkaline 
phosphatase conjugated anti-mouse polyvalent immunoglobulins (IgA, IgM, IgG) as 
secondary antibody. To analyse one type, the IgG type antibody response alkaline 
phosphatase conjugated anti-mouse IgG antibody was used. 
In this ELISA result, the highest immune response was found at 120 ng coated wells 
on test plates. 10 days after second immunization, all sera of mice showed anti-
RecP60 polyvalent and IgG antibody response over 0,8 RecP60 (120ng)  coated 
wells (Figure 3.5). According to the results, the most suitable amount for RecP60 
coating was determined as 120ng for following ELISA tests. 1st mouse which 
developed the highest IgG response against RecP60 was decided to be used for the 
1st fusion study. The second highest immune mouse, 4th mouse, was selected for the 
2nd fusion and the others were selected the same way, respectively. One week before 
every fusion, a booster immunization was done to the selected mouse as the 3rd 
immunization which was called rapel. After rapel, all mice which were used for 
fusions showed high IgG response over 1,5 in ELISA (to 120ng RecP60). Generating 
IgG response in mice was the evidence that the secondary immunization was done 
successfully. Obtaining IgG antibody response was important because it enhanced 
our chance to find hybridomas, producing IgG type antibodies. 
 60 
ELISA results of sera at different RecP60 concentration
0
0,2
0,4
0,6
0,8
1
1,2
1,4
1,6
1. mouse 2. mouse 3.mouse 4.mouse (-) C
Polyvalent response of mice sera at 1/200 dilution
O
D 
40
5 120ng
60ng
30ng
 
ELISA results of sera at different RecP60 concentration
0
0,2
0,4
0,6
0,8
1
1,2
1,4
1,6
1,8
2
1. mouse 2. mouse 3.mouse 4.mouse (-) C 
IgG responcse of mice sera at 1/200 dilution
O
D 
40
5 120ng
60ng
30ng
 
Figure 3.5 : Anti-RecP60 polyvalent and IgG antibody response of immunized 
BALB/c mice.  
 
 
 
 
3.2.2 Obtaining hybridomas by cell fusion studies 
Mice developed IgG response against RecP60 were selected to fuse their spleen and 
lymphoid cells with FO, myeloma cells. There were 7 fusions performed. For the 
first 6 fusions, the 2 fusions performed for one mouse: spleen and lymph node cells 
of the mouse fused with FO cells, separately. Only in the 7th fusion, cells of spleen 
and lymph node were mixed together and fused with FO cell line. In other words, 
only 1 fusion was performed with the mixture of two types of lymphocytes from the 
last mouse (Table 3.1). Following the fusion studies, at around day 10 hybrid 
colonies appeared. The culture medium (supernatant) was replaced with fresh 
medium in around every 10 days according to growing speed of the colonies and the 
supernatants were tested by ELISA.  
Each antibody responding cell was passaged into a large scale gradually and tested 
for its antibody response with its collected supernatants to watch antibody producing 
RecP60 was coated on ELISA test plates at different concentrations: 120ng, 
60ng, 30ng. Sera of mice were diluted in proportion to 1/200 with PBS for 
measuring their immune response. (-) C : negative control, non-immunized 
mouse. 
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continuity. They were named with the well number of which they were first grown in 
the 96 well plate. The name contains 2 number and 1 letter, for example 1G6, the 
first number represents the plate number, the following letter stands for the row and 
the last number corresponds to the column of the plate.  
As a result, from the 4th fusion only one, 3H4; from 7th fusion twelve, 1F8, 1G6, 
2B11, 2C8, 3H6, 4G1, 6B6, 6E3, 6G3, 7F11, 9H3 and 11D3 antibody producing 
hybridoma cells were obtained (Table 3.1). In the 7th fusion, 4G1, 6E3 and 11D3 lost 
their anti-RecP60 activity, the reason can be chromosome loss in the hybrid line.  
 1st fusion 2nd fusion 3rd fusion 4th fusion 
Number of spleen cells 75 x 106 - 71 x 106 - 
Number of lymphoid cells - 10 x 106 - 11 x 106 
Number of myeloma cells 7 x 106 3 x 106 56 x 106 18 x 106 
Number of wells for fusion 
plates 576 480 576 480 
Hybridoma cells 1 0 11 12 
Hybridoma cells 
producing  
antibody response 
0 0 0 1 (3H4) 
Hybridoma cells 
producing  
a-RecP60 response 
0 0 0 1 (3H4) 
 
 5th fusion 6th fusion 7th fusion 
Number of spleen cells - 110 x 106 
Number of lymphoid cells 130 x 106 - 
 
150 x106*  
 
Number of myeloma cells 30 x 106 30 x 106 60 x 106 
Number of wells for fusion 
plates 384 288 1056 
Hybridoma cells 15 10 1056 
Hybridoma cells producing  
antibody response 0 0 
12 (1F8, 1G6, 2B11, 2C8, 3H6, 4G1, 
6B6, 6E3, 6G3, 7F11, 9H3, 11D3) 
Hybridoma cells producing  
a-RecP60 response 0 0 6 (1G6, 3H6, 6B6, 6G3, 7F11, 9H3) 
*Spleen and lymphoid cells were mixed during 7th fusion. 
The specificities of obtained antibodies against RecP60 were tested by their cross 
reactivity against some proteins, such as BL21 and skim milk powder. BL21 lysate 
which was prepared from the cell lysate of E.Coli BL21 strain without pET-30a-
RecP60 vector, was used to detect whether an activity of a monoclonal antibody is 
observed against a bacterial protein that comes from RecP60 purification. Skim milk 
which was used in the blocking step of ELISA, was used to detect the activity of 
MAbs against the blocking agent.  
Table 3.1: Fusion conditions and results. 
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In the cross-reactivity ELISA, the activity of monoclonal antibodies against  RecP60, 
cellular lysate of BL21 and skim milk powder was compared. As a result, 3H4, 6B6 
and 6G3 monoclonal antibodies reacted mostly with RecP60. 1G6, 3H6 and 9H3 
recognized RecP60 higher than BL21 lysate and milk powder. 1F8, 2B11, 2C8 
showed high cross reactivity with milk powder and BL21. 7F11 differently 
recognized BL21 lysate higher than RecP60 (Figure 3.6). Although 1G6, 3H4, 3H6, 
6B6, 6G3, 9H3 seemed to recognize RecP60 specifically according to these results, 
all the 10 antibodies were tested for further characterization because there can be 
common epitops on these three proteins and on the native P60-Katanin. 
Cross-Reactivity Test
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Figure 3.6 : Cross-reactivity of the monoclonal antibodies. 
E.Coli BL21 lysate without pET30a and skim milk activity was compared with 
RecP60. 
The immune response of screening and cross-reactivity ELISA tests were visualized 
by anti-mouse polyvalent immunoglobulins (IgA, IgM, IgG). It was also tested 
whether these antibodies were IgG type or not. To understand that, the activity 
against RecP60 was compared with anti-mouse polyvalent immunoglobulins and 
anti-mouse IgG immunoglobulin. According to the ELISA results 1G6, 3H4, 3H6 
and 9H3 were found to be IgG type antibodies but 7F11 was not IgG, it could be 
either IgA or IgM type (Table 3.2).  
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 1G6 3H4 3H6 7F11 9H3 
Anti-RecP60 polyvalent response 1 1,7 1,1 1,4 1,6 
Anti-RecP60 IgG response 1,1 1,7 1,3 0,2 1 
 
As a summary, IgG type 3H4 from the 4th fusion; 1F8, 2B11, 2C8, 6B6 and 6G3 and 
IgG type 1G6, 3H6, 7F11 and 9H3 from the 7th fusion, hence in total 10 hybridoma 
cells and their the same named monoclonal antibodies were obtained. All the 
hybridoma cells were subcloned by limiting dilution and cultured in large scale. The  
hybrid cells were also frozen in freezing medium at -80oC to be stored for a long 
time.  
3.3 Characterization of Anti-RecP60 Monoclonal Antibodies 
Since the aim was producing monoclonal antibody that would recognize P60-
Katanin, it was necessary to select the antibody by examining it in further studies. 
Their monoclonal antibody containing supernatanats were collected for further 
selection and characterization studies to test if they recognize P60-Katanin of cells 
by Western-blotting and immunocytochemistry.  
3.3.1 Western-blotting with monoclonal antibodies 
Western-blotting studies were performed to test whether obtained MAbs would 
recognize native P60-katanin in tissues. Rat embryonic brain, rat embryonic liver 
tissue and HeLa cell lysates were used to test for all MAbs obtained after fusion 
studies. Liver and Hela cell line were chosen to represent the mitotic tissue and brain 
was chosen as nervous tissue. 50 µg/well tissue lysates were loaded on % 12 
polyacrylamide gel for SDS-PAGE. The six antibodies 3H4, 3H6, 6G3, 6B6, 7F11 
and 9H3 recognized RecP60 at 36 kDa but there was no significant protein band at 
55-65 kDa where native P60-katanin migrates. Only 1G6 recognized protein bands at 
55 kDa on brain and 65 kDa on HeLa lysate. Anti-β Tubulin and KATNA1 antibody 
were used as positive kontrol. Anti-β Tubulin antibody which was used as general 
Western-blotting method control (internal control), recognized a band at 55 kDa in 
Table 3.2: Isotype of anti-RecP60 monoclonal antibodies.  
1G6, 3H4, 3H6 and 9H3  were IgG type antibodies. 7F11 could  be either IgA or 
IgM. 
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all tissues. KATNA1 recognized a band at about 55 kDa in brain which was used to 
control visualizing P60-Katanin protein (Figure 3.7). β Tubulin staining showed us 
the steps of the method was performed succesfully. As KATNA1 was a commercial 
antibody produced against P60-Katanin,  it showed us that 1G6 reacts with the same 
molecular weight band where P60-Katanin migrates on nervous tissues. 
 
Figure 3.7 : Screening of monoclonal antibodies by Western-blotting.  
 
 
 
Because the method is more sensitive, chemiluminescant semi-dry Western-blotting 
was performed to examine 1G6 MAb recognition of P60-katanin in various tissues. 
In this method, 1G6 interaction with native P60-katanin in brain, brain stem, 
cerebellum, liver, lung, heart lysates of embryo and adult rat tissues were screened. 
As a result, 1G6 recognized a protein band at 55 kDa on brain, cerebellum and brain 
stem and 65 kDa on liver, lung, heart of adult and embryonic rats (Figure 3.8). 
Among the other MAbs, only 1G6 seemed to recognize P60 in all tissues. According 
to these results, supernatants of 1G6 were collected and 1G6 antibody was purified 
from the supernatant for further characterizations. After purification 1G6 was 
       1G6   KATNA1 
They recognized no significant band on lysates of brain and liver tissues and 
HeLa cell line except 1G6. Anti-β tubulin antibody were used as a positive 
control for tissue lysates.  
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examined again with Western-blotting, wide-cross-reactivity ELISA and 
immunocytochemistry. The same results were obtained with purified 1G6 that 
recognized P60-Katanin in tissues by Western-blotting. Wide-cross-reactivity-ELISA 
and immunocytochemistry results were told in the  next sections 3.3.2 and 3.3.3.  
 
Figure 3.8 : 1G6 recognition of P60-katanin in various tissue lysates by 
chemiluminescant Western-blotting. 
 
 
 
3.3.2 Purification of 1G6 monoclonal antibody 
Since 1G6 was found to recognize P60-katanin with Western-blotting, it was aimed 
to concentrate, store and purify 1G6 monoclonal antibody for further cross-reactivity 
ELISA tests and immunocytochemistry. For this purpose, 1G6 was cultued in large 
scale and its supernatnat was collected and protein precipitation by ammonium 
sulphate method was done. After dialysing the concentrated protein mixture of cell 
culture medium against PBS, 1G6 monoclonal antibody was purified by Protein-G 
Immunoaffinity Column Chromatography. 0,5 ml of fractions was collected after 
loading our sample into the column and absorbance was measured at 280 nm to 
follow the protein concentration changing during binding, washing and elution steps 
of purification. After purification, column fractions were also tested for ELISA 
against RecP60 to determine the tube number of the eluted antibody fractions and 
their antibody activity. 3H4 antibody was also purified with the same method as a 
control to compare their affinity alteration after purification.  
At the end of the study, anti-RecP60 activity and protein concentration analysis 
showed us that 3H4 and 1G6 were purified succesfully. As seen on graphs, after 
elution buffer (EB) was loaded onto the column, 1G6 was obtained in three tubes, 
The protein bands at 55kDa on brain, cerebellum and brain stem and  
65 kDa on liver, lung, heart of adult and embryo were shown by 
arrows. 
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15th-18th (0,5ml/tube) and 3H4 in 12th-14th tubes (1ml/tube) (Figure 3.9). The 
concentrations of purified antibodies were calculated by using absorbances of  
fractions at 280 nm and the equation of “1mg/ml solution of IgG antibody 
absorbances 1,43 at 280nm” in the formulas given below: 
Protein absorbance  /  1,43 (constant number)  =   Protein amount/ml (3.1) 
Protein amount/ml  x  Volume of the fraction (ml)   =  Total Protein amount  (3.2) 
 
 
Figure 3.9 : 1G6 (A) and 3H4 (B) purification fractions by Protein-G Immuno-
Affinity Column Chromatography.  
 
 
 
OD 405 represents anti-RecP60 activity of column fractions assayed by 
ELISA and OD 280 represents protein absorbances. EB: Elution buffer. 
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The protein concentrations of purified 1G6 fractions were calculated as follows: 15th 
fraction, 0.08 mg; 16th fraction, 1.02 mg; 17th fraction, 0.14 mg; 18th fraction, 0.025 
mg. The protein concentrations of purified 3H4 fractions was calculated as 
following: 12th fraction, 0.3 mg; 13th fraction, 0.06 mg; 14th fraction, 0.02 mg. 
According to calculations, pure 1G6 was obtained in 2 ml of total collected fractions 
at 0,63 mg/ml and 3H4 was obtained in 3 ml at 0,126 mg/ml.  
As seen on the graph of 3H4 purification, there was some anti-RecP60 activity 
before EB loading fractions. This could become if the antibody was overloaded into 
the column. It was seemed that after elution, the activity and concentration of the 
3H4 antibody increased, this shows us that elution was done on that step and 3H4 
was obtained purely because in washing fractions before elution there were no trace 
amounts of proteins observed at 280nm. 
For finding the optimum dilution of the newly purified antibody and incubation time 
of the substrate step of ELISA, it was necessary to examine different dilution ranges 
and substrate incubation times. To examine the activity of 1G6 and 3H4, cross-
reactivity ELISA test was performed widely with proteins such as milk powder, 
tubulin, BSA and another recombinant peptide, nRecP60, designed from P60-
Katanin. Tubulin was used to detect whether an activity of a monoclonal antibody 
was observed against this protein which P60-katanin interacts with. Since BSA and 
skim milk were used in ELISA assays as blocking agents, they were used in this 
assay to find out the better blocking agent for newly produced antibody. nRecP60, 
another antigen, was used to determine whether the antibody recognition part 
(epitop) of the antigen was common with its original antigen, RecP60. 1/100 and 
1/30 dilution of purified 1G6 and 3H4 were also applied in the assay to analyse the 
affect of dilution. The absorbance of 405 nm was measured 30 minutes and 1 hour 
after substrate addition (Figure 3.10).  
After obtaining the wide cross-reactivity test results firstly, 1G6 affinity to milk 
powder and RecP60 was controlled. After purification 1G6 activity to RecP60 was 
higher than the activity against skimmed milk powder (Figure 3.10 C) which was the 
same as the activity of unpurified 1G6 (Figure 3.6). No alteration of the recognition 
of RecP60 and skim milk was also observed for 3H4 after purification, which 
showed that the purification method was successful for 1G6 and 3H4. 
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Figure 3.10 : Cross reactivitiy ELISA of 1G6 and 3H4 with several proteins. 
             Milk p.: skim milk powder 
 
Then, the affinity of 1G6 to other proteins was controlled (Figure 3.10). Purified 1G6 
reacted with RecP60 (60, 120ng) and nRecP60 (60,120, 240 ng) higher than skim 
milk and tubulin (60, 120, 240 ng). 1G6 activity against BSA was equal to 120 ng 
RecP60 activity, higher than 60 ng RecP60 activity, but lower than all concentrations 
of nRecP60 activity. When RecP60 and nRecP60 concentrations were increased (60, 
120, 240), the activity of 1G6 also increased. When tubulin concentration was 
increased no activity of 1G6 increased. These results showed that 1G6 has high 
affinity to the two kinds of RecP60, designed from native P60-katanin and also 
interacts lower with skim milk and BSA but no significant activity was found with 
tubulin. According to these results it is suggested that 1G6 recognized the epitops of 
RecP60 and nRecP60 which were so similar to the specific epitop of native P60-
katanin, the epitopic structure of BSA and skim milk was less similar to the epitop of 
P60 and there is no similarity with the epitop of tubulin. Purified 3H4 which was 
used as control only reacts with RecP60 and nRecP60 which showed us that 1G6 
reacts with the epitops different from 3H4.  
To analyse the affect of dilution factor to the antibodies affinity to different proteins, 
1/100 and 1/30 dilution of purified 1G6 and 3H4 were applied in the assay. The 
absorbance of 405 nm was measured after 30 minutes and 1 hour after substrate 
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addition and compared to monitor the most active time of antibodies. To find the 
optimum dilution of the newly purified antibody and incubation time of the substrate 
step of ELISA for the diluted antibody, it was necessary to examine the combination 
of different dilution ranges and substrate incubation times.  It was expected that 
when dilution of antibodies increased, the activity of antibodies would decrease. This 
affect was observed at 30th minute of substrate addition and application of 1/100 and 
1/30 dilution of 1G6 and 3H4 (Figure 3.10 A and B). In this examination, the 
increase of 1G6 activity is higher than 3H4 because the concentration affect to the 
activity was also important for the antigen recognition and it is changeable for 
different antibodies. For 1G6 1/30 dilution was optimum, for 3H4 1/100 dilution was 
optimum. In ELISA assays, the measurement for the binding activity of the 
antibodies increased when the incubation time after substrate addition increased. 
From our previous results, it was determined that 1 hour was optimum for our ELISA 
tests to catch the minimum activity. It was also observed in this examination that, at 
1/30 dilution of each antibodies and on the 1st hour of substrate addition their 
activities were higher then the 30th min. This high measurement allowed us to 
compare the cognition patterns of different proteins with 1G6 because the difference 
between their measurements were more than the measurements at 30th min. 
Therefore, 1 hour incubation time for substrate step and 1/30 dilution were suitable 
for purified 1G6 (Figure 10 C). The activity of 3H4 was not quantified when it 
reaches over 4 at this conditon (Figure 10 C) but its increasing activity was seen on 
increased dilution and dicreased substrate incubation conditions observed at Figure 
10 A and B.  
3.3.3 Immunoflourescence staining of P60-katanin in mitotic cells with 1G6 
Obtained IgG type anti-RecP60 antibodies were examined whether they recognize 
P60-katanin in cells by immunocytochemistry. The method was performed on cell 
lines from different species. Human origin HeLa and SHSY-5Y  neuroblastoma and 
mouse origin NIH/3T3 fibroblast cells were fixed with different types of fixation 
methods. Paraphormaldehyde, gluteraldehyde and methanol fixation methods were 
tried to find out the optimum method for our antibody stainings. MAbs were 
examined with their supernatant and also with their purified forms. 
Flourescence labelled secondary antibodies, Alexa 488 anti-mouse IgG antibody; 
Alexa 546 anti-mouse IgG antibody; Cy5 anti-mouse IgG antibody, were used to 
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visualize our mouse originated monoclonal antibodies’ affinity. In dividing cells, 
only one monoclonal antibody, 1G6, reacted with P60-katanin specifically. In Figure 
3.11-13, 1G6 showed the expected P60 interaction with the microtubular structure, 
detected by previous studies (Karabay et. al., 2004; McNally and Thomas, 1998).  
 
 
Figure 3.11 : Immunocytochemistry analysis of  P60-katanin by 1G6. 
 
 
 
 
 
According to the results of single staining, 1G6 appeared to stain P60-katanin of 
HeLa, neuroblastoma and fibroblast cells showing the specific localization on the 
mitotic spindle, also on astral microtubules (Figure 3.11A), and on the remains of 
spindle microtubules at telophase (Figure 3.11B). In three kinds of fixation methods, 
there was no significant difference with 1G6 staining. Also three types of secondary 
antibody did not significantly change the visualization of 1G6 interaction (Figure 
3.11, 3.12, 3.13).  
 
Dividing HeLa cell was photographed at different z-positions and arranged 
as series (1-9). 1G6 staining was localized on the mitotic apparatus in every 
section (A). 1G6 stained the remains of spindle microtubules of HeLa cells 
at telophase (B). The fixation was done with paraphormaldehyde, 
supernatant of 1G6 and Alexa 546 anti-mouse IgG antibody was used as 
secondary antibody. 
 71 
 
 
 
Figure 3.12 : 1G6 localization on dividing HeLa cells.  
 
 
 
 
Figure 3.13 : Immunocytochemistry analysis of P60-katanin in different cell lines. 
 
 
  
 
Dual 1G6 and tubulin staining were also performed to show the known interactions 
of P60-katanin localization on microtubule. Methanol fixed HeLa cells were stained 
with 1G6 and rabbit anti-β tubulin antibodies. Alexa-488 anti-mouse IgG was used to 
The fixation was done with glutaraldehyde and Alexa 546 anti-mouse IgG 
antibody (A) and Alexa 488 anti-mouse IgG antibody (B) were used as 
secondary antibodies. 
1G6 localized on the mitotic spindle of SHSY-5Y neuroblastoma (A) and NIH/3T3 
fibroblast (B). In these studies, gluteraldehyde (A) and methanol fixation (B) and 
Cy5 anti-mouse IgG antibody was used.  
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visualize 1G6 and Alexa-647 anti-rabbit IgG antibody was used to visualize β 
tubulin interaction. 
As a result, 1G6 staining merged with β tubulin staining image was such that 1G6 
was localized on the mitotic spindle and concentrated specifically on the 
microtubules towards the spindle poles; different from β tubulin staining which is 
distributed on the entire microtubules of mitotic spindle in dividing cells (Figure 
3.14).  
 
 
 
 
Figure 3.14 : Comparison of tubulin and P60-katanin localization on the mitotic 
spindle.  
 
 
 
 
 
HeLa cells were stained with 1G6 (green, left panel) and anti-β tubulin 
antibodies (red, middle panel). The right panel shows the overlay of both 
signals. 
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According to the results, 1G6 showed the expected P60-katanin interaction with 
microtubules and recognized P60-katanin of two species, human and mouse. These 
results are also consistent with the information that P60-katanin was available on 
microtubules to control the length of microtubules which is necessary for the phases 
of cell division.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.15 : Analysis of human P60-katanin expressed in dividing HeLa cells.  
 
 
 
 
To observe the recognition pattern of overexpressed P60-katanin with 1G6 on 
extrinsic katanin expression, HeLa cells were transfected with human originated full 
P60-katanin which was previously cloned into pEGFP-C1 vector. After transfection, 
cells were plated and fixed-permeabilized with methanol at 4th, 8th, 12th, 24th, 48th and 
72th hours of incubation to determine different expression levels of P60. After 
staining with 1G6 and chicken anti-GFP antibody, Cy5 conjugated anti mouse-
P60-GFP expression (green, middle panel) became dense at the poles of mitotic 
apparatus and merged with 1G6 staining (red, left panel). The right panel shows 
the overlay of both signals. 
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antibody and FITC conjugated anti-chicken IgY antibody was used for secondary 
antibody to visualize staining. The forced overexpressed P60-katanin seemed to 
specifically concentrate on the spindle poles (Figure 3.15) preferentially at first, 
which is expected with P60-katanin’s known function. 
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4.  DISCUSSION  
Microtubule severing is an important mechanism for cellular activities. In mitosis 
and meiosis, microtubule severing on the spindles is thought to contribute to spindle 
reorganization (Ahmad and Baas, 1995). In neurons, all neuronal microtubules are 
suggested to be severed to relocate to populate in growing processes such as axons 
and dendrites (Baas et al., 2005). P60-katanin  is the microtubule severing subunit of 
the heterodimeric katanin protein which has also P80 subunit that enhances the 
severing activity (Hartman et al., 1998). Katanin is concentrated at a microtubule-
dependent structure at mitotic spindle poles, suggesting katanin may sever 
microtubules from their centrosomal attachments in non-neuronal cells (McNally and 
Thomas, 1998).  In neurons, the level of P60-katanin was found to be very high in 
axons actively growing toward their targets, but then it decreased when the axon 
reached its target and stopped growing (Yu et al., 2005).  
In this study, we produced the first monoclonal antibody against P60-katanin, using 
rat sequence based RecP60 (Recombinat P60-katanin) protein as antigen. Soluble 
RecP60 was prepared succesfully. Hybridoma technology was performed and 10 
MAbs were produced. Cross-reactivity ELISA tests, Western-blotting and 
immunocytochemistry were performed for selection of the specific antibody. Only, 
1G6 recognized native P60-katanin showing the specific cellular localization and 
protein migration. 
4.1 Properties of Recombinant P60-Katanin Protein  
In this study, our aim was firstly to overexpress P60-katanin for anti-P60-katanin 
monoclonal antibody production. In order to obtain accurate folded P60-Katanin 
protein, an amino acid sequence named as RecP60, was selected from full rat P60-
katanin protein sequence regarding the inclusion of specific and soluble antigenic 
determinants. To achieve the specificity, the conserved C-terminal AAA domain was 
excluded from the full length of P60. To solve the solubility and folding problem, 
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  1  MSLLMITENV KLAREYALLG NYDSAMVYYQ GVLDQINKYL YSVKDTHLHQ KWQQVWQEIN 
 61 VEAKHVKEIM KTLESFKLDS TSLKAAQHEL PSSEGEVWSL PVPVERRPLP GPRKRQSTQH 
121 SDPKPHSNRP GAVVRAHRPS AQSLHSDRGK AVRSREKKEQ SKGREEKNKL PAAVTEPEAN 
181 KFDSTGYDKD LVEALERDII SQNPNVRWYD IADLVEAKKL LQEAVVLPMW MPEFFKGIRR 
241 PWKGVLMVGP PGTGKTLLAK AVATECKTTF FNVSSSTLTS KYRGESEKLV RLLFEMARFY 
301 SPATIFIDEI DSICSRRGTS EEHEASRRVK AELLVQMDGV GGASENDDPS KMVMVLAATN 
361 FPWDIDEALR RRLEKRIYIP LPSAKGREEL LRISLRELEL ADDVNLASIA ENMEGYSGAD 
421 ITNVCRDASL MAMRRRIEGL TPEEIRNLSR EEMHMPTTME DFEMALKKVS KSVSAADIER 
481 YEKWIVEFGS C 
hydrophobic regions and cystein residues were excluded. In other words, the amino 
acid sequence of N-terminus part (amino acids 1-194) of the full length rat P60-
katanin was selected to make the soluble N-terminal His6-tag recombinant P60 
protein (Figure 4.1 ). 
Figure 4.1: The amino acid sequence of full length rat P60-katanin  (Gene Bank, the        
 
 
 
 
According to SDS-PAGE analysis, overexpressed RecP60 was detected as 35 kDa. 
Molecular weight of RecP60 must have been about 22 kDa (22167.08 Da) which was 
calculated from its amino acid sequence by using Expasy PI tool 
(http://expasy.org/tools/pi_tool.html). When RecP60 was expressed in the pET30a 
construct His-tag, thrombin, S-tag, enterokinase and 5 proline residues and some 
additional amino acid sequences were fused hence its weight becomes 35 kDa.  
Mutation resulting in amino acid change can affect activity or folding of the 
expressed protein. After cloning of selected P60-katanin cDNA sequence into pET-
30a expression vector, no shift mutation was observed according to nucleotide 
sequencing results, but a point mutation (purine-purine) was found. The mutation 
resulted in CGA instead of CAA that changed the encoding for glutamine to arginin. 
Antigen fits to its antibody due to complementarity in shape over an area of contact 
by non-covalent bonding. Protein folding proceeds by  moving the hydrophobic parts 
of the protein inwards, and the hydrophilic ones outwards. RecP60 structure should 
not be altered significantly by the mutation because glutamine and arginine are both 
hydrophilic amino acids, so the surface exposition of that amino acid would 
supposedly not change. 
European Molecular Biology Laboratory, accession No. AY621629). 
Expressed RecP60 is selected from N-terminus part (underlined). Conserved C-
terminal AAA domain (bold); Non-polar (Hydrophobic) aminoacids (blue). 
Extensive hydrophobic parts are marked in gray. Cystein residues are marked in 
yellow.  Point mutation that changed glutamine (Q) to arginin (R) is marked in 
green. 
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The best conditions for obtaining RecP60 were determined considering the factors 
that affect the protein solubility. The amino acid sequence of a recombinant protein 
determines the physical properties of the protein, including its stability, pI, 
hydrophobicity, and molecular weight, any or all of which might directly affect the 
expression and solubility levels and accuracy of the folding process (Tsunoda et al., 
2005). Cystein residues that are responsible for disulfide bond formation in protein 
folding process were also excluded because any possibility for wrong disulfide bond 
formation might result in wrong folding (Baneyx, 1999). After SDS-PAGE of total 
cell protein analysis, it was observed that the overexpressed RecP60 was in soluble 
fraction. 
Overexpressed soluble RecP60 was purified from the bacterial culture to further use 
in mice immunization. Natural or denaturating conditions is possible for protein 
purification by Ni-NTA resin. Since expressed RecP60 was obtained soluble, 
purification under natural conditions was choosen. Moreover, such purification 
condition does not distort protein conformation which is important for immunization 
efficiency.   
4.2 Monoclonal Antibody Production 
In this part RecP60 was used as antigen and produced MAbs against RecP60 by 
hybridoma technology. MAb 1G6 was the only antibody that recognized P60-katanin 
on mitotic apparatus in dividing cells. MAb 1G6 was found to be specific for P60-
katanin and able to show the cellular P60-katanin and can be used to investigate its 
functions.  
Our hybridoma technology study started by the generation of RecP60 specific B cells 
via immunization of female BALB/C mice. Immunized female mice generated strong 
IgG response after second immunization which means that immunization procedure 
was done successfully. At some methods, addition of carrier proteins or methods for 
conjugation of antigen was recommended for achieving immunization. 35 kDa of our 
antigen was enough when dissolved in PBS and mixed with Freund’s adjuvant as an 
injection material for immunization.  
In the next step, the fusion of immunized spleen B cells, which with myeloma cells, 
and selection of the specific hybridoma clone by ELISA were performed. After the 
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fusion step, increasing the number of colonies which were observed in fusion culture 
plates would be proportional to increase the chance for obtaining the specific 
antibodies. In other words, the obtained hibridoma cell number was important. The 
problems obtaining low hybridoma cell number was solved by changing several 
factors of the method. Since the cells were starting to die after sacrification of mice, 
the fusion step must be performed rapidly to maintain cell viability. The chemical 
fusion process would also make cells sensitive. Therefore, starting from the 
sacrification to fusion process, every step were performed rapidly and gently to 
maintain cell surviving by gaining experience. Cell culturing conditions were also 
changed. Culture media was prepared from powdered DMEM and CO2 concentration 
of the incubator was calibrated to 5 %. After all optimization procedures, the yield 
from the fusions were increased and it reached to the top in the last fusion which 
resulted in qualified antibody 1G6. 
Hybridoma cells appeared after 10 days from the fusion and their media was replaced 
with the fresh one in around every ten days. Each antibody activity of replaced media 
was tested by ELISA. Because the secreted antibody was in a low amount which 
were produced from little colony of cells at the beginning, ELISA tests were done for 
two times for each cell to catch antibody producing cells. In addition, to determine 
antibody producing cells in their early growing period, the most antigen coating 
amount which was 120 ng was used in these screening method and cross-reactivity 
ELISA tests. This technique acquires us most of the antibody producing cells 
correlated with the number of proliferated hibridomas. From the 4th fusion only one, 
from the 7th fusion 12 anti-RecP60 antibody producing hybridoma cells were 
obtained. Each antibody producing cells was screened by ELISA to test if their 
antibody producing property continued. 10 hybrid cells maintained their antibody 
producing activity and 3 of them lost their activity, the reason could be releated with 
the chromosome loss in the hybrid line.  
Screening monoclonal antibodies only against RecP60 is not enough to decide if they 
are specific or not. In the immune response of the organism, all the antibodies 
secreted into serum of the RecP60 immunized mouse showed polyclonal anti-
RecP60 activity. However, when their sources were isolated and cultured 
individually, they had different antigen affinity properties. Antibody-antigen affinity 
belongs to epitop interaction and there can be common epitops in different proteins. 
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To investigate a certain protein, its specific recognition by the antibody is needed 
which requires the recognition of its epitop, that is not present in other proteins, only 
belonging to the certain protein. Also in screening ELISA tests, milk powder was 
used as blocking agent. The antibody activity could be against milk powder rather 
than RecP60. Therefore, cross-reactivity ELISA tests were performed for 
understanding recognition properties of obtained antibodies. 3 of the antibodies 
highly cross reacted with RecP60, cellular lysate of BL21 and skim milk powder. 6 
of the monoclonal antibodies including 1G6 reacted mostly with RecP60 than BL21 
lysate and skim milk. 1 antibody differently recognized BL21 lysate higher than 
RecP60. The 6 antibodies reacted mostly with RecP60 were potential specific anti-
RecP60 antibodies.  
Since the aim was producing monoclonal antibody that recognize native P60-katanin 
to investigate its function in further methods, their recognition properties in Western-
blotting and immunocytochemistry were also need to be determined because the 
epitop that was presented at the surface of the protein also may change due to the fact 
of conditions of the method the antibody would be tried. Therefore, all the 10 
antibodies were tested for these methods because there can be similar epitops 
recognized on these three proteins exposed in the conditions of ELISA, but specific 
when exposed on the native P60-katanin in the conditions of immunocytochemistry 
and Western-blotting methods. These further characterization methods would be 
discussed in Section 4.3. 
Resultant hybridomas must be single-cell cloned and then expanded as individual 
clones, which secrete only one antibody to be monoclonal antibodies. Therefore, 
cloning them by “limiting dilution” and the up-scaling of MAb production was done.  
Isotypes of the obtained antibodies were also determined and 5 of them including 
1G6 were IgG type. The majority of monoclonal primary antibodies for use in 
immunocytochemistry (ICC) and Western-blotting are of the IgG Isotype because 
recognition of the antigen by IgG monoclonal antibodies tend to be more specific 
than other types of antibodies. Therefore, obtaining monoclonal antibodies of IgG 
isotype is an advantage and this can be achieved by generating secondary 
immunization against the antigen. 
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4.3 Characterization of Anti-RecP60 Monoclonal Antibodies 
In this part recognition properties of all 10 MAbs in Western-blotting and 
immunocytochemistry were determined, although there were only 6 potential 
antibodies including 1G6 that would recognize native P60 specifically according to 
cross-reactivity test. Due to the conditions of cross-reactivity ELISA, common 
epitops of the proteins could be recognized by one antibody but the same epitop 
could be specific when exposed on the native P60-katanin in the conditions of 
immunocytochemistry and Western-blotting methods. Therefore, to understand the 
monoclonal antibody specificity to P60, it is neeeded to be tried in Western-blotting 
and immunocytochemistry methods which P60-katanin staining and migration 
patterns were known. 
Western-blotting studies were performed to test whether obtained MAbs would 
recognize 55-65 kDa native P60-katanin in tissues. Western-blotting of P60-katanin 
with 1G6 on cell lines and tissues yielded protein bands at 65kDa and 55kDa 
indicating that there may be alternative spliced forms of  P60-katanin depending on 
tissue types. A 65 kDa band was obtained on liver, heart, lung of adult and 
embryonic rat tissues and HeLa, SHSY-5Y and NIH/3T3 cell lines; which were all 
mitotic. A 55kDa band was shown to be present in non-mitotic cerebellum and brain 
tissues of adult and embryonic rat tissues and also in the brain stem of adult rat 
tissue. From these results, it is possible to think that 1G6 MAb interacts with the 
common epitop of alternative spliced forms of P60-katanin of both tissues.  
In the wide-cross-reactivity ELISA, purified 1G6 recognition was examined with 
proteins such as milk powder, tubulin, BSA and another recombinant P60 protein 
nRecP60 (Figure 4.2). 1G6 activity to RecP60 and nRecP60 was higher than skim 
milk and BSA, but no significant activity of 1G6 was found with tubulin. According 
to results, it was suggested that 1G6 reacts with the similar epitop of native P60-
katanin and RecP60, nRecP60 and epitop structure of BSA and skim milk was less 
similar with P60-katanin in ELISA. Antibodies show activity by interacting with the 
epitope region of the antigen. In different methods, proteins may fold differently and 
may present different epitopic structures. The recognition of the antigen by antibody 
specifically depends on the presentation of the specific epitop of the antigen in the 
applied method, so each antibody may not be suitable for each method. In ELISA, 
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  1  MSLLMITENV KLAREYALLG NYDSAMVYYQ GVLDQINKYL YSVKDTHLHQ KWQQVWQEIN 
 61 VEAKHVKEIM KTLESFKLDS TSLKAAQHEL PSSEGEVWSL PVPVERRPLP GPRKRQSTQH 
121 SDPKPHSNRP GAVVRAHRPS AQSLHSDRGK AVRSREKKEQ SKGREEKNKL PAAVTEPEAN 
181 KFDSTGYDKD LVEALERDII SQNPNVRWYD IADLVEAKKL LQEAVVLPMW MPEFFKGIRR 
241 PWKGVLMVGP PGTGKTLLAK AVATECKTTF FNVSSSTLTS KYRGESEKLV RLLFEMARFY 
301 SPATIFIDEI DSICSRRGTS EEHEASRRVK AELLVQMDGV GGASENDDPS KMVMVLAATN 
361 FPWDIDEALR RRLEKRIYIP LPSAKGREEL LRISLRELEL ADDVNLASIA ENMEGYSGAD 
421 ITNVCRDASL MAMRRRIEGL TPEEIRNLSR EEMHMPTTME DFEMALKKVS KSVSAADIER 
481 YEKWIVEFGS C 
the monoclonal antibodies that show affinity to RecP60, may also show some 
activity against BSA and milk powder. In addition, the same antibodies may be 
specific only to P60-katanin in immunocytochemistry and Western-blotting methods. 
According to this information and the results of wide-cross-reactivity ELISA, it was 
suggested that presented epitops of RecP60 and nRecP60 in ELISA which were 
recognized by 1G6 were so similar to P60-katanin's specific epitope and 1G6 showed 
less activity to BSA and skim milk suggested that the epitopic structure of the latter 
proteins has a less similarity with the specific epitop of P60. 
The wide-cross ELISA results were also consistent with the cross ELISA results 
obtained with supernatants of the antibodies. This showed that after purification there 
were no alteration about the antibodies’ recognition. 
 
Figure 4.2: The aminoacid sequence of nRecP60.  
 
 
Obtained IgG type anti-RecP60 antibodies were examined whether they would 
recognize P60-katanin in cell lines by immunocytochemistry. The results of 
immunocytochemistry studies with 1G6 also showed the evidence that P60-katanin 
was available on microtubules for its regulation to control the length of microtubules 
which is necessary for the phases of cell division (McNally K, 2006).  
The immunocytochemistry studies also indicate that 1G6 MAb is specific to P60-
katanin of two species, mouse and human, because it recognized native P60-katanin 
of human origin HeLa, SHSY-5Y Neuroblastoma cells and mouse origin NIH/3T3 
Fibroblast cells. 1G6 was obtained by immunizing mouse with RecP60 which was 
expressed based on the sequence of rat P60-katanin. Aminoacid sequences of human 
P60-katanin and mouse P60-katanin were blasted with rat P60-katanin and gave a 
high homology of 93 % with human and 95 % with mouse. This indicated that it is 
The amino acid sequence of RecP60 (red and blue) and nRecP60 (blue) was 
marked in full sequence of rat P60-katanin. 
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possible for 1G6 to recognize P60-katanin of three types of organisms, and this 
observation was confirmed with our immunocytochemistry and Western-blotting 
studies. 
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5.  CONCLUSION 
P60-katanin is a microtubule severing protein. Katanin promotes spindle-shortening 
and severing processes in mitotic and meiotic spindles. In neurons, the level of P60-
katanin was found to be very high in actively growing axons and at the tips of 
growing neuronal processes and in dendritogenesis. Katanin is one of the key protein 
for organizing microtubular structure of a variety of cell types.  
In this study, we produced 1G6, the first monoclonal antibody against P60-katanin. 
RecP60, which was produced based on a specific region of rat P60-katanin, was 
expressed in Escherichia coli and used as antigen. 10 MAbs were produced by 
hybridoma technology. Only, 1G6 recognized native P60-katanin in Western-blotting 
and immunocytochemistry in which monoclonal antibody would increase the range 
of applications. 1G6 is the first monoclonal antibody, showing the specific cellular 
localization of P60-katanin and can be used to investigate P60-katanin’s functions. 
This antibody would also extend the range of applications, especially would enable 
multiple stainings. Since P60-katanin polyclonal antibodies have been used in studies 
until now, obtaining the hybridoma cell, the unlimited source of a monoclonal 
antibody against P60, results in a great advantage to investigate P60-katanin’s 
functions. 
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